Physiogard Touch 7
Physiogard Touch 7
Physiogard Touch 7
TOUCH 7 TOUCH 7
User guide
* 0-48-0227 *
Art. no.: 0-48-0227 Rev.: g
1
Sales and Service Information
The SCHILLER sales and service centre network is world-wide. For the address of your
local distributor, contact your nearest SCHILLER subsidiary.
In case of difficulty, you can find a complete list of all distributors and subsidiaries on our
Internet site:
http://www.schiller.ch
Sales information can also be obtained from:
sales@schiller.ch
Manufacturer
SCHILLER MEDICAL Phone +33 3 88 63 36 00
4, rue Louis Pasteur Fax +33 3 88 94 12 82
F- 67160 Wissembourg E-mail: info@schiller.fr
Web: www.schiller-medical.fr
The DEFIGARD Touch7 bears the CE-0459 mark (Notified Body LNE/G-MED), indicating its compli-
ance with the essential requirements of the Annex I of the Medical Device Directive 93/42/EE re-
garding safety, functionality and labelling. The requirements apply to patients, users and third per-
sons who come into contact with this device within the scope of its intended use. First declaration
26.04.2015
The PHYSIOGARD Touch 7 bears the CE-0459 mark (Notified Body LNE/G-MED), indicating its com-
pliance with the essential requirements of the Annex I of the Medical Device Directive 93/42/EE re-
garding safety, functionality and labelling. The requirements apply to patients, users and third per-
sons who come into contact with this device within the scope of its intended use. First declaration
7.04.2016
Table of Contents
1 Safety notes .............................................. 9
1.1 User profiles.......................................................................... 9
1.2 Intended Use ......................................................................... 9
1.3 Contraindication for use .................................................... 10
1.4 Responsibility of the User ................................................ 11
1.5 Organisational Measures ................................................... 11
1.6 Safety-Conscious Operation ............................................. 12
1.7 Operation with other Devices ............................................ 13
1.8 Maintenance........................................................................ 13
1.9 Hygiene................................................................................ 14
1.10 Networks and Internet ........................................................ 14
1.11 Additional Terms ................................................................ 15
1.11.1 Implied Authorisation........................................................................ 15
1.11.2 Terms of Warranty ........................................................................... 15
1.12 Display Symbols/Indicators............................................... 16
1.12.1 Symbols Used in this User Guide .................................................... 16
1.12.2 Symbols used on the device ............................................................ 17
1.12.3 Symbols Used on the Batteries........................................................ 18
1.12.4 Symbols Used on the Electrode Package........................................ 19
Page 3
DEFIGARD/PHYSIOGARD Touch 7
4 Monitoring ...............................................36
4.1 Soft keys, Waveforms and Measurement Fields ............. 36
4.1.1 View selection .................................................................................. 37
4.2 Alarm System...................................................................... 38
4.2.1 Alarm priority.................................................................................... 38
4.2.2 Operator’s position........................................................................... 38
4.2.3 Alarm list .......................................................................................... 38
4.2.4 Physiological alarms ........................................................................ 39
4.2.5 Technical alarms.............................................................................. 39
4.3 Operator-Defined Alarm Thresholds................................. 40
4.3.1 Table of wide/narrow threshold setting ............................................ 41
4.4 ECG and heart rate monitoring ......................................... 43
4.4.1 Quick Diagnosis of the ECG Using Defibrillation Electrodes ........... 43
4.4.2 Connecting a 4- or 10-wire ECG patient cable ................................ 43
4.4.3 Connecting a 4-wire ECG patient cable........................................... 44
4.4.4 Connecting a 10-wire ECG patient cable......................................... 44
4.4.5 Starting ECG monitoring .................................................................. 45
4.4.6 Monitoring a pacemaker patient....................................................... 46
4.4.7 Curve list .......................................................................................... 47
4.4.8 HR Module (ECG)............................................................................ 47
4.4.9 ECG messages................................................................................ 47
4.4.10 Print and pdf formats........................................................................ 48
4.5 Diagnostic ECG (R-ECG).................................................... 49
4.6 SpO2-, SpCO, SpMet monitoring (Option) ........................ 50
4.6.1 Inaccurate or incorrect measurement result .................................... 51
4.6.2 Starting SpO2 monitoring and test................................................... 52
4.6.3 SpO2 Module ................................................................................... 52
4.6.4 SpO2error and information messages .............................................. 53
4.7 NIBP monitoring ................................................................. 55
4.7.1 Starting NIBP monitoring ................................................................. 57
4.7.2 NIBP Menu....................................................................................... 58
4.7.3 NIBP Information and Error Messages ............................................ 58
4.8 IBP Monitoring .................................................................... 59
4.8.1 Preparing an IBP measurement....................................................... 59
4.8.2 Start IPB measurements.................................................................. 60
4.8.3 IBP menu settings............................................................................ 60
4.8.4 IBP zeroing ...................................................................................... 61
4.8.5 IBP alarms/messages ...................................................................... 61
4.9 Temperature monitoring .................................................... 62
4.9.1 Start temperature monitoring ........................................................... 62
Art. no.: 0-48-0227 Rev.: g
Page 4
DEFIGARD/PHYSIOGARD Touch 7 User guide
5 Defibrillation ........................................... 78
5.1 Application guidelines and safety notes .......................... 78
5.1.1 Additional safety information for AED Mode .................................... 79
5.1.2 Defibrillating children/neonates ........................................................ 80
5.2 General function ................................................................. 81
5.2.1 Activating the manual defibrillation mode......................................... 82
5.2.2 Activating the automated (AED) defibrillation mode......................... 83
5.2.3 Manual defibrillation procedure ........................................................ 84
5.3 Manual Defibrillation Using Pads...................................... 85
5.3.1 Applying the adult and paediatric electrodes ................................... 85
5.3.2 Applying the electrodes.................................................................... 86
5.3.3 Checking the electrodes................................................................... 87
5.3.4 Manual Defibrillation Using Pads Procedure.................................... 88
5.4 Synchronised defibrillation ............................................... 89
5.4.1 Warning erroneous triggering........................................................... 89
5.4.2 Setup switching from synchronized to unsynchronized mode ......... 89
5.4.3 Function of the Synchronized Defibrillation Procedure .................... 90
5.4.4 Synchronised defibrillation procedure .............................................. 91
5.5 Semi-automated defibrillation ........................................... 92
5.5.1 Semi-automated defibrillation (AED) procedure............................... 92
5.5.2 Voice messages in AED Mode......................................................... 93
5.5.3 Defibrillation procedure .................................................................... 94
5.6 CPR Guide........................................................................... 96
5.6.1 SCHILLER LifePoint......................................................................... 96
5.6.2 FreeCPR .......................................................................................... 97
5.6.3 Metronome settings.......................................................................... 97
Art. no.: 0-48-0227 Rev.: g
Page 5
DEFIGARD/PHYSIOGARD Touch 7
6 Pacemaker ...............................................99
6.1 Pacemaker Function........................................................... 99
6.1.1 Fixed-rate mode (Fix)....................................................................... 99
6.1.2 Demand mode ................................................................................. 99
6.2 Safety Notes ...................................................................... 100
6.3 Guidelines for the Application of External Pacemakers 100
6.3.1 Attaching the pacer pads ............................................................... 101
6.3.2 Checking the electrodes ................................................................ 101
6.4 Start-up of the Pacemaker ............................................... 102
6.4.1 Pacemaker display......................................................................... 103
6.4.2 Selecting pacemaker mode ........................................................... 103
6.4.3 Pacemaker settings operational mode fix ...................................... 104
6.4.4 Demand Mode ............................................................................... 105
6.4.5 Switching from pacemaker to defibrillation .................................... 105
10 Maintenance ..........................................112
10.1 Maintenance interval ........................................................ 112
10.1.1 Maintenance Interval Table............................................................ 112
10.1.2 Service/Shelf life ............................................................................ 113
10.2 Functional test .................................................................. 114
10.2.1 Visual inspection of the device and accessories............................ 114
10.2.2 Battery check ................................................................................. 114
10.2.3 Defibrillator key test ....................................................................... 114
10.2.4 Auto Test ....................................................................................... 115
10.2.5 Functional test - measured values ................................................. 115
10.2.6 Alarm tests ..................................................................................... 115
10.3 Update Software .............................................................. 117
10.3.1 Update via USB ............................................................................. 117
Art. no.: 0-48-0227 Rev.: g
Page 6
DEFIGARD/PHYSIOGARD Touch 7 User guide
Page 7
DEFIGARD/PHYSIOGARD Touch 7
13 Appendix ...............................................159
13.1 Accessories and disposables ......................................... 159
13.2 Accessories DEFIGARD/PHYSIOGARD Touch 7........... 159
13.3 Literature ........................................................................... 161
13.4 Glossary ............................................................................ 161
14 Index ......................................................163
Page 8
Safety notes 1
DEFIGARD/PHYSIOGARD Touch 7 User guide User profiles 1.1
1 Safety notes
The PHYSIOGARD® Touch 7 is a monitor.
Other persons The DEFIGARD® Touch 7 can be used by other persons (AED mode only if trained
in early defibrillation).
Training An initial training of at least 30 minutes is necessary and sufficient to use the device.
Page 9
1 Safety notes
1.3 Contraindication for use DEFIGARD/PHYSIOGARD Touch 7
NIBP
The NIBP monitor is intended for use as an aid or adjunct to diagnosis and
treatment when it is necessary to measure an adult, child and neonate patient’s
blood pressure. The NIBP can be used for patients of both sexes and all races.
This NIBP can be used on pregnant patients or patients suffering from pre-
eclampsia
IBP
Invasive blood pressure: systolic, diastolic and mean pressure.
SpO2, SpCO, SpMet
The Masimo Rainbow SET® Pulse CO sensor is indicated for use with adult and
paediatric patients during both no-motion and motion conditions, and for patients
who are well or poorly perfused.
etCO2
The IRMA mainstream sensor is intended to be connected to a patient breathing
circuit for the continuous non invasive monitoring of breath rate and inspired/
expired gases during anaesthesia, recovery and respiratory care.
The ISA gas analyser is intended to be connected to a patient breathing circuit
for the continuous non invasive sidestream monitoring of breath rate and
inspired/expired gases during anaesthesia, recovery and respiratory care.
The CO2 sensors are intended for use with adult, paediatric and infants
populations.
Page 10
Safety notes 1
DEFIGARD/PHYSIOGARD Touch 7 User guide Responsibility of the User 1.4
Page 11
1 Safety notes
1.6 Safety-Conscious Operation DEFIGARD/PHYSIOGARD Touch 7
and verify the readings according to section 10.2.5 page 115.
Page 12
Safety notes 1
DEFIGARD/PHYSIOGARD Touch 7 User guide Operation with other Devices 1.7
1.8 Maintenance
Art. no.: 0-48-0227 Rev.: g
Danger of electric shock! Do not open the device. No serviceable parts inside.
Refer servicing to qualified personnel only.
No modification of this equipment including sensor and accessories is allowed.
Before cleaning, switch the unit off and remove the battery.
Do not use high temperature sterilisation processes
(such as autoclaving). Do not use E-beam or gamma radiation sterilisation.
Do not use solvent or abrasive cleaners on either the unit or cable assemblies.
Do not, under any circumstances, immerse the unit or cable assemblies in liquid.
Page 13
1 Safety notes
1.9 Hygiene DEFIGARD/PHYSIOGARD Touch 7
1.9 Hygiene
For cleaning and disinfection observe the legal requirements applicable.
Only use cleaning agents and disinfectants recommended by SCHILLER.
Unsuitable agents can damage the device. Clean and disinfect the device in
accordance with the instructions given in this book.
Page 14
Safety notes 1
DEFIGARD/PHYSIOGARD Touch 7 User guide Additional Terms 1.11
In case of a defect, send the apparatus to your dealer or directly to the manufacturer.
The manufacturer can only be held responsible for the safety, reliability, and
performance of the apparatus if:
There are no express or implied warranties which extend beyond the warranties
hereinabove set forth. SCHILLER makes no warranty of merchantability or fitness for
a particular purpose with respect to the product or parts thereof.
Art. no.: 0-48-0227 Rev.: g
Page 15
1 Safety notes
1.12 Display Symbols/Indicators DEFIGARD/PHYSIOGARD Touch 7
For a direct danger which could lead to severe personal injury or to death.
For a possibly dangerous situation, which could lead to heavy bodily injury or to death.
For a possibly dangerous situation which could lead to personal injury. This symbol is
also used to indicate possible damage to property.
Used for electrical dangers, warnings and other notes in regarding operation with
electricity.
NOTE for possibly dangerous situations which could lead to damages to property or
system failure or IMPORTANT for helpful user information.
Touch-sensitive areas
This symbol is used to designate touch-sensitive areas that might not be self-evident.
Move up or down.
Page 16
Safety notes 1
DEFIGARD/PHYSIOGARD Touch 7 User guide Display Symbols/Indicators 1.12
Signal input type CF: Highly isolated port, defibrillation protected. However, it is only
defibrillation protected when used with the original SCHILLER patient cable.
The user can take the following measures to solve this problem:
• Increase the distance between the disturbed device and the DEFIGARD/
PHYSIOGARD Touch 7. A minimum distance of 20 cm must be kept between the
device and a pacemaker.
• Turn the device to change the antenna's angle of radiation.
• Connect the device to a different mains connector.
For more details, see section 10.9.3 Measures to prevent electromagnetic
interferences page 126.
Page 17
1 Safety notes
1.12 Display Symbols/Indicators DEFIGARD/PHYSIOGARD Touch 7
IP55 The device is protected against dust and spraying water from all directions.
Expiration date
Rechargeable battery
Page 18
Safety notes 1
DEFIGARD/PHYSIOGARD Touch 7 User guide Display Symbols/Indicators 1.12
• Open clothes
• Open the electrode package
• Peel off the protective foil
Expiration date
Latex free
Keep dry
Page 19
2 Components and Operation
2.1 Design DEFIGARD/PHYSIOGARD Touch 7
The PHYSIOGARD® Touch 7 includes the same features as the DEFIGARD® Touch
7, but without the defibrillation function.
Biocompatibility
The parts of the product described in this user guide, including all accessories, that
come in contact with the patient during the intended use, fulfil the biocompatibility
requirements of the applicable standards. If you have questions in this matter, please
contact SCHILLER.
2.1 Design
Power supply The DEFIGARD® Touch 7 and PHYSIOGARD® Touch 7 is powered by an integrated
rechargeable battery. The capacity of one battery is sufficient for:
Monitoring According to its configuration, the DEFIGARD® Touch 7 and PHYSIOGARD® Touch
Art. no.: 0-48-0227 Rev.: g
Data storage All intervention data – resting ECG data, lead II ECG, defibrillator ECG, SpO2 curves,
trends, events, patient data.
Data transmission • Easy transmission of a 12-lead ECG, trends and screenshots by WLAN or GSM
during intervention
• GSM, WLAN, Ethernet (via USB adapter) Communication, for software and
configuration updates and post-intervention data (PDF or Sema format)
transmissions.
Page 20
Components and Operation 2
DEFIGARD/PHYSIOGARD Touch 7 User guide Design 2.1
• SCHILLER Charging Unit CS-1. External charging and calibrating unit for
rechargeable batteries.
• DC/DC or AC/DC ambulance charging bracket. Holds the device securely while
recharging the battery inside the device.
• AC/DC desktop charging bracket. Holds the device while recharging the battery
inside the device.
• AC/DC Nomad charger
• DC/DC Nomad charger
Page 21
2 Components and Operation
2.2 Operating Elements DEFIGARD/PHYSIOGARD Touch 7
Battery/DC Supply
Status or Alarm LED
Status LED
NIBP
SpO2
Optional Trunk
Art. no.: 0-48-0227 Rev.: g
Page 22
Components and Operation 2
DEFIGARD/PHYSIOGARD Touch 7 User guide Operating Elements 2.2
Battery/DC Supply
Status or Alarm LED
Status LED
NIBP
SpO2
Optional trunk
NIBP cable for CO2
Art. no.: 0-48-0227 Rev.: g
Page 23
2 Components and Operation
2.2 Operating Elements DEFIGARD/PHYSIOGARD Touch 7
Dovetail fixing
joint
2.2.4 LEDs
The LEDs give the following information:
Page 24
Components and Operation 2
DEFIGARD/PHYSIOGARD Touch 7 User guide Operating Elements 2.2
2.2.5 Display
Filter mode: Monitoring, Rhythm or Diagnostic Patient Information
Network status
Intervention duration
Display field for system and alarm mes-
sages. Touch to show alarm list Battery charging status
Date/time
Alarm Status
Black and white dis-
SpO2: Startup state
play Off
Adult
HR
ECG calibration
impulse 1 mV Heart Rate
NIBP
NIBP
Waveform field
SpO2 and Tempera-
ture
Start Manual
Defibrillation (DEFIGARD Touch
The display can vary according to the settings and used options and selected views.
The following screen is displayed when swiping from right to left, see above.
Adult Off
HR
Art. no.: 0-48-0227 Rev.: g
Page 25
3 Initial Operation
3.1 External DC supply and Battery Operation DEFIGARD/PHYSIOGARD Touch 7
3 Initial Operation
Please read the safety notes in section 1 Safety notes page 9 before initial
operation.
Danger of explosion! The device is not designed for use in areas where an
explosion hazard may occur. Also, it is not permitted to operate the defibrillator
in an oxygen-enriched environment or in the presence of flammable substances
(gas) or anaesthetics. Oxygenation in the vicinity of the defibrillation electrodes
must be strictly avoided.
Danger of electrical shock. The DEFIGARD® Touch 7 is a high-voltage therapy
device. Improper use of the device can endanger life. Always follow the
instructions given in this user guide.
The user must make sure that there are no conductive connections between the
patient and other persons during ECG analysis and defibrillation.
Avoid defibrillation in very moist or wet surroundings.
To avoid the risk of electric shock, this equipment must only be connected to a
supply mains with protective earth.
Page 26
Initial Operation 3
DEFIGARD/PHYSIOGARD Touch 7 User guide External DC supply and Battery Operation 3.1
Important
The power battery is automatically recharged when the device is connected to the
external DC supply via the docking station (LED 2). The power battery requires
1 2 approx. 2 hour to be recharged at 90%.
The recharging of the battery is indicated by the LED above the battery symbol.
If the temperature in the device becomes too high, the charging is stopped. As soon
as the temperature has decreased to an acceptable level, the charging resumes.
Battery status
Press on the battery icon. The following information will be displayed:
• Charge level in %
• Estimated autonomy in hours and minutes
• Estimated number of shock possible with the remaining capacity
Art. no.: 0-48-0227 Rev.: g
Page 27
3 Initial Operation
3.1 External DC supply and Battery Operation DEFIGARD/PHYSIOGARD Touch 7
• The device does not need to be switched off. Monitoring is continued. The device
is powered by the safety primary cell for another 30 seconds; after that, the device
is switched off automatically.
• The battery can only be inserted in one way.
2. To remove the battery, press the two blue catches to release and remove the bat-
tery.
Click!
The device can be connected to an external direct-current source via the docking
station.
device.
Art. no.: 0-48-0227 Rev.: g
Page 28
Initial Operation 3
DEFIGARD/PHYSIOGARD Touch 7 User guide External DC supply and Battery Operation 3.1
Power supply
module AC/DC or DC/DC
Click!
2 1
Putting the device on the charging bracket Removing the device from the charging bracket
Simply put the device back on the wall mounting. Pull the release lever towards the device (1) and pull
The device is locked automatically. You should the device upwards (2), while keeping the lever in the
clearly hear the click of the locking mechanism release position.
The device can easily be slid onto the desktop charging bracket.
Page 29
3 Initial Operation
3.1 External DC supply and Battery Operation DEFIGARD/PHYSIOGARD Touch 7
During transportation, the device can be fixed on a rail (e.g. bed or stretcher rail)
Page 30
Initial Operation 3
DEFIGARD/PHYSIOGARD Touch 7 User guideSwitching off and disconnecting from the external DC supply
3.2
Restart The “Restart” function is used to exit the Post-Intervention or the control panel menu
No directly by restarting the device instead of switching it on and off.
Lock the Touch screen In the ON/OFF dialogue, select “ Lock touch screen”.
Unlock Touch screen Press the button twice. The message appears “Touch screen unlocked”
Note: If you touch the locked touch screen, a message prompts you to press the ON/
OFF button twice to unlock the screen.
Furthermore the residual energy stored in the defibrillator 100 ms after shock release
is always discharged internally.
Page 31
3 Initial Operation
3.2 Switching off and disconnecting from the external DC supply DEFIGARD/PHYSIOGARD Touch 7
• Do not expose the device to direct sunlight, or extremely high or low temperatures.
The ambient temperature should be in the range of 0°C to 40 °C. Lower or higher
ambient temperatures will have a negative impact on the battery's life.
To ensure its readiness for use, the device runs a self-test to check the unit and the
battery. A self-test can be performed any time. An enhanced periodic test can be
performed in a defined interval (standard setting every 5 weeks) and at a defined time
(standard setting 12:00)
An auto test can be executed anytime see paragraph 10.2.4 Auto Test.
Page 32
Initial Operation 3
DEFIGARD/PHYSIOGARD Touch 7 User guide Operation 3.3
3.3 Operation
The menus can be accessed as follows:
---
Adult Off
HR
NIBP
---
Adult Off
HR
Trends
R-ECG
Art. no.: 0-48-0227 Rev.: g
Screenshots
Stop Intervention
00547_160318_103611
Fig. 3.5 Display with main menu and the touch-sensitive areas
Page 33
3 Initial Operation
3.4 Printing DEFIGARD/PHYSIOGARD Touch 7
3.4 Printing
The following data can be printed on the Bluetooth printer:
• Recorded Resting ECG (incl. patient data, patient vitals, interpretation and ECG
curves)
• Screenshots (+/- 5 sec from the moment of the screenshot that contains all
displayed curves, patient data and vital data)
• Intervention report.
Communication media
menu indicates .
6. Select “Printer test page” to check the printing function.
Printer
idle
eCPR system
Data Transmission
In case of communication problem with a Bluetooth device, switch it off and on again.
Scan again for the Bluetooth device.
For detailed information, refer to the Brother P4030 printer user guide.
1. Press and hold the (Power) button to switch off the printer.
2. Open the cover (1).
2 3. Insert the RD Roll into the compartment (2).
4. Close the cover.
5. Press and hold the (Power) button to turn the printer on.
Art. no.: 0-48-0227 Rev.: g
6. Press the (feed) button to set the paper in the right starting position.
1
Page 34
Initial Operation 3
DEFIGARD/PHYSIOGARD Touch 7 User guide Connection to a ePCR system 3.5
Data Transmission
Transmission list
Communication history • Please contact your local SCHILLER distributor for compatible ePCR systems list
or interface request.
Communication media • In case of communication problem with a Bluetooth device, switch it off and on
Printer
again. Scan again for the Bluetooth device.
Art. no.: 0-48-0227 Rev.: g
eCPR system
Page 35
4 Monitoring
4.1 Soft keys, Waveforms and Measurement Fields DEFIGARD/PHYSIOGARD Touch 7
4 Monitoring
Operation and menu access is detailed on page 33.
Adult Off
HR
NIBP
Settings
The settings that are defined in the menus are set to default when the unit is switched
off.
Page 36
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide Soft keys, Waveforms and Measurement Fields 4.1
The display can vary according to the settings and used options. The default views
are displayed as described below:
Basic monitoring
with 2 ECG leads and SpO2 curve, big measurements filed with heart
rate, NIBP and SpO2 values.
Advanced monitoring
with 2 ECG leads, SpO2, EtCo2 curve, measurements filed with heart
rate, NIBP SpO2, ETCO2, RR and Temp values.
Critical care
with 2 ECG leads, SpO2, EtCo2, IBP curve, measurements filed with
heart rate, SpO2, Temp, etCO2, RR, IBP and NIBP values.
Art. no.: 0-48-0227 Rev.: g
12 lead ECG
with all 12 ECG leads.
As the displayed ECG is online and filtered with diagnostic filters the
curves may be sensitive to motion artefacts. For better ECG quality it
is advised to perform a "R-ECG" see paragraph 4.5.
Page 37
4 Monitoring
4.2 Alarm System DEFIGARD/PHYSIOGARD Touch 7
Ensure that the environmental noise is below the alarm sound volume of 65 dB.
The visual alarm LED is visible to a distance of 4 meters and the flashing value is
visible to a distance of 1 meter.
Alarm List
08h02m43s: HR out of range (P-ECG03)
HR out of range
08h02m43s:SpO2: Sensor Off Patient (T-SP229)
Page 38
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide Alarm System 4.2
Page 39
4 Monitoring
4.3 Operator-Defined Alarm Thresholds DEFIGARD/PHYSIOGARD Touch 7
Access the threshold menu by pressing the alarm icon and selecting Wide Quick set
or Narrow quick set.
• With the Default key, the default threshold values are activated.
• With the Quick Set selection, all values are derived from the current measured
Alarm Settings Default
values. See table on the following page.
Wide Quick Set
Make sure that the patient’s vital parameters are not critical before pressing the
Narrow Quick Set button Quick Set.
Audio Pause
Audio OFF
• The operator-defined Quick set thresholds will be set to the default values after
switching off the device.
Page 40
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide Operator-Defined Alarm Thresholds 4.3
Page 41
4 Monitoring
4.3 Operator-Defined Alarm Thresholds DEFIGARD/PHYSIOGARD Touch 7
Page 42
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide ECG and heart rate monitoring 4.4
Important
• The guidelines for patient electrode placement are provided as an overview only.
They are not a substitute for medical expertise.
• If an electrode is faulty or has come off, a message indicates the faulty electrode.
Isoelectric segments are excluded from the corresponding lead arc duration
measurements (Q, R, S waves). Isoelectric parts (I-wave) are also excluded in the
duration measurement of the respective adjacent waveform. (For more detailed
information, see 2.530036c Statement_of_accurracy 3ed_ETM.
For a quick diagnosis, the ECG signal can be recorded from the patient's thorax using
the defibrillation electrodes. In all other situations, we recommend acquiring the ECG
via ECG electrodes and the patient cable.
To apply the electrode pads, see section 5.3.1 Applying the adult and paediatric
electrodes page 85.
The 4 + 6 wires cable is a two-part cable that provides the standard four monitoring
(limb) electrode leads with the option of adding the 6 chest leads to provide a full 12-
leads diagnostic ECG without the need to change the cable and remove the limb
electrodes.
Refer to the following pages for the electrode placement of the 4-wire cable. Connect
the blanking connector to the cable junction.
The electrode placement for the 10-wire cable is the same as for the 10-wire standard
cable described on the following pages. The blanking connector must be removed and
the connector for the additional 6 wires placed in the socket on the cable junction.
Page 43
4 Monitoring
4.4 ECG and heart rate monitoring DEFIGARD/PHYSIOGARD Touch 7
Red Yellow
When a patient cable as well as the defibrillation electrodes are connected, you can
select the heart rate signal source by touching the first curve (standard ECG:II) on the
Black Green display and selecting ECG Defi. The first display curve is used to calculate the heart
rate unless the HR source is set to Pleth.
C2 yellow
C6 purple
Black Green
Art. no.: 0-48-0227 Rev.: g
Page 44
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide ECG and heart rate monitoring 4.4
QRS complexes are represented by green vertical dashes above the top ECG curve,
pacemaker pulses by red vertical dashes.
Curve list with a 10-wire cable
---
Adult Off
Curve List HR
ECG: Defi
ECG: I NIBP
ECG: II
ECG: III
ECG: aVr
Curve List
ECG: II R-ECG Event Screenshot Manual Def Start Menu
ECG: Defi
ECG
Back to Default
HR source
Art. no.: 0-48-0227 Rev.: g
Amplitude
ECG filters
Page 45
4 Monitoring
4.4 ECG and heart rate monitoring DEFIGARD/PHYSIOGARD Touch 7
When monitoring the heart rate of pacemaker patients, it is important that the device
will only count the QRS complexes and reject the pacer pulses.
Pacemaker impulses are represented by red vertical dashes above the top ECG
curve.
The device has an electronic pacer pulse suppression algorithm which rejects the
pacer pulses so that they are not counted as QRS complexes. Depending on the
pacemaker model used and on the position of the electrodes, the compensation pulse
following every pacer pulse may be considered as a QRS complex. In this situation
and when the pacer pulse is ineffective, the displayed heart rate may lead to a
misinterpretation, and the device will not issue an alarm in the case of bradycardia or
asystole. Whether or not the compensation pulse is counted as a QRS complex
depends on the pacer pulse parameters.
For pacemaker patients, the ECG signal amplitude should be greater that 1 mV.
If the source of the heart rate is SpO2, this is indicated by the blue HR (Pleth)
measurement field instead of the green HR measurement field.
Page 46
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide ECG and heart rate monitoring 4.4
a. When the patient has a cardiac pacemaker, the HR source must be set to Pleth (see page 46).
No Patient • Unable to calculate heart rate Check the ECG cable and electrodes
Check patient
Art. no.: 0-48-0227 Rev.: g
Page 47
4 Monitoring
4.4 ECG and heart rate monitoring DEFIGARD/PHYSIOGARD Touch 7
Page 48
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide Diagnostic ECG (R-ECG) 4.5
7. It is now possible to scroll the R-ECG in the x-y axis for reviewing.
8. Transmit the ECG with following options:
Press ”Send” to transmit the file via the defined transmission path e.g GSM/3G/
Wi-Fi, Bluetooth to:
– SEMA
– e-mail
– USB storage
Press “Print” to print the ECG to an external Bluetooth printer.
Press “Interpr.” to open the interpretation information.
Press ”Measur.” to open the measurement information
Art. no.: 0-48-0227 Rev.: g
• If transmission of the data fails, the error icon appears in the top right status bar.
The failed transmitted data can be re-sent in the main menu “R-ECG”.
• If you close the R-ECG Window without sending the data, the data can be re-sent
via the main menu “R-ECG”.
For detailed information about the transmission, see chapter 4.6 page 50.45
• The resting ECG speed displayed on the recording depends on the configured
printout- or pdf format (see chapter 4.4.10 Print and pdf formats, page 48).
• To display all 12 ECG leads see chapter 4.1.1 View selection, page 37.
Page 49
4 Monitoring
4.6 SpO2-, SpCO, SpMet monitoring (Option) DEFIGARD/PHYSIOGARD Touch 7
• The pulse oximeter enables the continuous, non invasive monitoring of functional
oxygen saturation of arterial haemoglobin as well as the pulse rate. The signal
received from the patient sensor is used to calculate the patient's functional oxygen
saturation and pulse rate.
• The Masimo Rainbow SET® technology for SpCO and SpMet measurements is
based on the same principles as pulse oximetry. The Masimo Rainbow SET
technology uses a multi-wavelength sensor to distinguish between oxygenated
blood, deoxygenated blood, blood with carbon monoxide, blood with oxidized
haemoglobin and blood plasma. Once the Masimo Rainbow SET technology
receives the signal from the sensor, it calculates the patient's functional oxygen
saturation (SpO2), fractional concentration of carboxyhaemoglobin (SpCO),
fractional concentration of methaemoglobin (SpMet) and pulse rate.
• The display shows the continuous progress of the numeric SpO2 value, pulse rate,
plethysmographic waveform and signal quality.
• The displayed plethysmographic curve is not proportional to the pulse volume.
• The update period of the measurement readings on the display is 0.2 seconds.
• According to the relevant standards, the temporary alarm suppression must not
exceed 2 minutes.
• Equipment used to perform functional tests cannot be used to give an indication as
to the accuracy of the SpO2 module.
• SpO2, SpCO and SpMet are empirically calibrated in healthy adult volunteers with
normal levels of carboxyhaemoglobin (COHb).
• The peak wavelength and maximum optical power of the light emitted by the pulse
oximeter probes has to be considered in certain cases, e.g. when performing
photodynamic therapy. They are as follows:
– Range of peak wavelengths: 600 nm to 900 nm
– Maximum optical power output LNCS sensor: <15 mW
– Maximum optical power output Rainbow sensor: <25 mW
• Masimo sensors use LEDs that are non-laser with the SpO2 module.
• High-intensity extreme lights (such as pulsating strobe lights) directed on the
sensor, may not allow the pulse co-oximeter to obtain vital sign readings.
Page 50
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide SpO2-, SpCO, SpMet monitoring (Option) 4.6
Only use SpO2, SpCO and SpMet sensors listed in the order information for the
DEFIGARD/PHYSIOGARD Touch 7. Other oxygen transducers (sensors) may
lead to improper performance.
The information in this user guide does not overrule any instructions given in the
sensor's user guide, which must be consulted for full instructions.
Never use the pulse oximeter as the sole means of monitoring a patient or as an
apnoea monitor- always use the pulse oximeter in combination with an ECG
trace.
Never use a pulsoximeter during MR imaging. Induced current could potentially
cause burns and the pulse oximetry may affect the image and accuracy of the
measurements.
Tissue damage can be caused by incorrect application or use of a sensor.
Inspect the sensor application location as described in the sensor directions to
ensure skin integrity and correct positioning and adhesion of the sensor.
Do not use damaged patient cables, damaged sensors or sensors with exposed
optical components.
Change the position of the sensor at least every 4 hours, and every 2 hours if
the perfusion is low.
When patients are undergoing photodynamic therapy, they may be sensitive to
light sources. Pulse oximetry may be used only under careful clinical supervision
for short time periods to minimize interference with photodynamic therapy.
Page 51
4 Monitoring
4.6 SpO2-, SpCO, SpMet monitoring (Option) DEFIGARD/PHYSIOGARD Touch 7
1. Apply the SpO2 sensor to the patient. Insert the patient's forefinger into the probe
as far as it will go, and make sure that the finger tip covers all of the probe window.
This is to prevent that extraneous light reaches the photodetector.
2. Connect the SpO2 sensor to the device and secure the cable with the two velcro
fasteners.
3. Check the bar graph for signal quality (1).
4. Check Perfusion Index PI level (3).
5. Set the narrow SpO2 alarm limit see page 40.
6. When the SpO2 value exceeds the alarm limit (2), an alarm is issued.
Set the alarm limit to narrow or wide when the vital data are not critical.
Perfusion Index PI (3) with trending capability indicates arterial pulse signal strength
and may be used as a diagnostic tool during low perfusion.
2 1 PI display ranges from 0.02% (very weak pulse strength) to 20% (very strong pulse
strength).
a. When the patient has a cardiac pacemaker, the HR source must be set to Pleth (see page 46).
Page 52
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide SpO2-, SpCO, SpMet monitoring (Option) 4.6
Page 53
4 Monitoring
4.6 SpO2-, SpCO, SpMet monitoring (Option) DEFIGARD/PHYSIOGARD Touch 7
Page 54
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide NIBP monitoring 4.7
The automatic measurements are suitable also for pregnant or pre-eclamptic patient.
Make sure that the cuff is on a level with the heart during blood pressure
measurements. If this is not ensured, the hydrostatic pressure of the liquid column in
the blood vessels will lead to incorrect results. When the patient is sitting, standing or
supine during measurements, the cuff is automatically at the correct level.
Factory default cuff pressure adult = 180 mmHg, children = 150 mmHg,
neonates = 50 mmHg
The initial cuff pressure is configurable. The maximum cuff pressure configuration in
neonatal mode is 150 mmHg.
cuff and hose as far away as possible from the operated area and the
electrosurgical cables. Make sure that the electrosurgical return conductor
(neutral) is well attached to the patient and that a good contact is guaranteed.
In some patients petechiae, haemorrhages or subcutaneous haematomas may
occur. All patients must be told when putting on the cuff that if they experience
pain during the recording they should switch off the equipment and inform the
doctor.
When an automated measurement interval is defined, bruising or decreased
blood circulation can occur in the arm. Only carry out recordings with automated
measurement intervals under constant medical supervision.
It must be certain that, according to the health of the patient, the use of the
device will not damage blood circulation in the arm.
Page 55
4 Monitoring
4.7 NIBP monitoring DEFIGARD/PHYSIOGARD Touch 7
Page 56
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide NIBP monitoring 4.7
Manual
The following settings are available for the cycle time:
Venous Block
Automatic Cycles 2/3/5/10/30 minutes
Manual The measurement is manually initiated by pressing the soft key.
Venous Block The venous block is used to apply an intravenous access. The
pressure is exactly 40 mmHg. The blockage time is limited to 80
second. You can stop anytime the blockage by the NIBP Stop
key.
Off
Adult
HR
START
NIBP
V. BLOCK
1:30
R-ECG Event Screenshot Manual Def Start Menu
Art. no.: 0-48-0227 Rev.: g
• When the measurement is started, the increasing cuff pressure is displayed on the
bar graph.
• The last four measurements are displayed in the window.
Page 57
4 Monitoring
4.7 NIBP monitoring DEFIGARD/PHYSIOGARD Touch 7
• Pressure in the cuff remains too Check cuff and connection for leaks
Cuff not present T.NIBP13
low < 10 mmHg during 10 s
T.NIBP15 • Measurement disturbed by ex- The patient must not move during meas-
Artefacts detected urement
T.NIBP16 ternal influences
T.NIBP18 • Pumping running time exceed- Check cuff and connection for leaks.
Inflate timeout
T.NIBP19 ed
No pulse I.NIBP01
Check patient, cuff and hose
Page 58
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide IBP Monitoring 4.8
• The kit and operating procedure vary according to manufacturer. Please consult
the manufacturer's documentation for connection.
• For warm-up time/ready for measurement and displacement for invasive
transducers, refer to the documentation of the transducer manufacturer.
1. Unpack the disposable measuring kit and check all tube connections for tight-
ness.
2. Secure the infusion bag and connect the infusion tube to the bag.
3. Fill up the system with liquid so it is completely void of air.
4. Hang the measuring kit in the holder and secure the holder.
5. Connect the cable of the transducer to the adaptor cable.
6. Connect the adapter cable to the DEFIGARD/PHYSIOGARD Touch 7 IBP input.
Art. no.: 0-48-0227 Rev.: g
Page 59
4 Monitoring
4.8 IBP Monitoring DEFIGARD/PHYSIOGARD Touch 7
1. Select the IBP measurement field (1) to open the IBP menu.
2
2. Select OFF/ON button (2) to start the measurement.
3. Zeroing the IBP (see Zeroing)
4. Check the IBP curve on the display to see if the connections have been made
Start measurement ON correctly and the IBP value is in the expected range.
Zeroing 1
Curve amplitude (mmHg)
HR
Page 60
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide IBP Monitoring 4.8
Sens
Set three-way
valve to
ambient
Patie
• Try to zeroing during valid patient Check catheter valve is closed during zeroing
measurement
Zero not possible I_IBP01
Art. no.: 0-48-0227 Rev.: g
Page 61
4 Monitoring
4.9 Temperature monitoring DEFIGARD/PHYSIOGARD Touch 7
Page 62
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide CO2 mainstream 4.10
Page 63
4 Monitoring
4.10 CO2 mainstream DEFIGARD/PHYSIOGARD Touch 7
3
HME
Page 64
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide CO2 mainstream 4.10
• The sensor requires a warm-up time of around ten seconds to provide fully
accurate measurements.
• A correction related to O2 usage is available in the menu setting EtCO2>Type of
ventilation. If patient is ventilated with Air and O2, set Type of ventilation to =
“Air + O2” if ventilated only with air set it to “Air”.
1. Connect the sensor cable to the main cable (1). Snap the sensor head on top of
the airway adapter. Make sure it clicks into place.
2. A green LED indicates that the sensor is ready for use.
3. Select the EtCO2 measurement field (2) to open the EtCO2 menu. “
1 4. Select OFF/ON button (3) to start the measurement.
5. Check if the etCO2 value is zero.
6. If needed, carry out a zeroing (see page 66).
7. Connect the narrower end of the airway adapter to the breathing circuit Y-piece.
2
8. Connect the end of the airway adapter to the patient’s endotracheal tube.
9. Check the CO2 curve on the display to see if the connections have been made
correctly and the CO2 value is in the expected range. The curve rises during ex-
piration.
3
Start measurement ON
Perform zeroing
Type of ventilation
Air
Page 65
4 Monitoring
4.10 CO2 mainstream DEFIGARD/PHYSIOGARD Touch 7
Zeroing intervals for • When the message “CO2 calibration is required” is displayed
CO2 IRMA sensor • When an offset in gas readings is discovered (0-offset)
Zeroing procedure 1. Snap a new airway adapter onto the sensor without connecting the airway adapt-
er to the breathing circuit.
2. After start-up or changing of the adapter, wait for at least 10 seconds until the
sensor has reached its operating temperature.
3. In the "etCO2 settings" menu, select the menu item “Perform zeroing”.
4. Carry out the zeroing by pressing the parameter “Perform zeroing” in the "et-
CO2 settings" menu. Make sure that no exhaled air enters the airway adapter.
The green LED on the probe will be blinking for approximately 5 seconds while
zeroing is in progress.
5. If the message “CO2 calibration is required” is again displayed, perform the
zeroing again.
6. If the message “CO2 calibration is required” is no longer displayed, the zero-
ing has been performed.
7. Reconnect the airway adapter with the sensor to the breathing circuit.
8. Check the CO2 curve on the display to see if the connections are correct and if
the CO2 value is in the expected range. The curve rises during expiration.
Page 66
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide CO2 mainstream 4.10
Page 67
4 Monitoring
4.10 CO2 mainstream DEFIGARD/PHYSIOGARD Touch 7
Zeroing in progress T.ETCO202 • Zeroing process started Wait till zeroing process ends
Motor speed out of bounds T.ETCO220 • Sensor failure Check sensor, replace sensor
Factory calibration lost T.ETCO221 • Sensor failure Check sensor, replace sensor Art. no.: 0-48-0227 Rev.: g
Page 68
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide CO2 Sidestream 4.11
4.11 CO Sidestream
2
The ISA sidestream gas analyzer is intended for use by authorized healthcare
professionals only.
Disposable sampling lines must not be reused. Used sampling lines should be
disposed of in accordance with local regulations for contaminated and
biologically hazardous fluids.
Only use Masimo´s Nomoline sampling lines.
Do only use sample lines intended for anaesthetic agents if N2O and/or
anaesthetic agents are being used.
Make sure to select the correct configuration:
– Do not use T-adapter sampling line configurations for infants because these
will add 7 ml dead space to the patient circuit.
– Do not use the Nomoline Airway Adapter Set Infant with adult/paediatric pa-
tients.
Use only airway T-adapters with the sampling point in the centre of the adapter,
see picture on the left.
Do not use the sampling lines with metered-dose inhalers or nebulized
medications as this may clog the bacteria filter.
The ISA sensor is not intended to be used as the only means of monitoring a
patient.
Excessive positive or negative pressure in the patient circuit (e.g. excessive
scavenging suction pressure) might lead to incorrect readings.
Exhaled gases should be returned to the patient circuit or scavenging system;
do not apply negative pressure to the Nomoline (i.e. by means of a syringe) to
remove condensed water.
Always use a bacteria filter on the evacuation side if sampled gas is intended to
be re-breathed.
Use of high frequency electrosurgical equipment in the vicinity of the ISA sensor
may produce interference and lead to incorrect measurements.
Exhaust gases should be returned to the patient circuit or to a scavenging
system.
Art. no.: 0-48-0227 Rev.: g
The Nomoline sampling line and its interface are non-sterile devices. To avoid
damage, do not autoclave any part of the sampling line.
Do not apply tension to the sensor cable.
Do not operate the device at temperatures outside the specified operating
environment.
Make sure that the ISA sensor is properly secured in order to prevent damages
to the sensor.
The use of a sampling line with an inner diameter of more than 1 mm can lead
to a change in the response and rise time of the CO2 measurement. When the
respiration rate is higher than 130/min, this might lead to a lower etCO2 value
being displayed.
Page 69
4 Monitoring
4.11 CO2 Sidestream DEFIGARD/PHYSIOGARD Touch 7
The Nomoline sampling line is designed for single use only; do not reuse.
Page 70
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide CO2 Sidestream 4.11
Replace the sampling line if the sampling line input connector (2) starts flashing
red or the message “Sampling line clogged” is displayed on the device.
Connect the gas sample exhaust port to the gas exhaust of the bag to prevent
Green/Red LED that CO2 enriched gas in the bag influences the zeroing of the ISA gas analyser
Start measurement ON
Perform zeroing
Type of ventilation
Air
In addition to the information given on the screen, the sensor LED indicates the
following:
Page 71
4 Monitoring
4.11 CO2 Sidestream DEFIGARD/PHYSIOGARD Touch 7
Zeroing in progress T.ETCO202 • Zeroing process started Wait till zeroing process ends
Sampling line clogged T.ETCO207 • Indicates sampling line occlusion. Replace sampling line
T.ETCO208 • Indicates that a sampling line Check if IRMA CO2 adapter is properly
No sampling line
needs to be fitted. connected
Internal O2 port failure T.ETCO209 • Sensor failure If persistent, replace sensor
T.ETCO214 • Temperature Sensor to hight/low Check standard operating condition if
Internal temp out of range normal:
Replace sensor
T.ETCO215 • Pressure to high/low Check standard operating condition if
Ambient pressure out of normal:
range
Replace sensor
T.ETCO216 • This alarm is due to Zeroing Check standard CO2 condition if normal:
Inaccurate zero reference
required message from the probe. Perform zeroing
Software error T.ETCO218 • Sensor failure Check sensor, replace sensor
Motor speed out of bounds T.ETCO220 • Sensor failure Check sensor, replace sensor
Factory calibration lost T.ETCO221 • Sensor failure Check sensor, replace sensor
Art. no.: 0-48-0227 Rev.: g
Page 72
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide CO2 Sidestream 4.11
• The ISA sidestream gas analyser performs zeroing automatically by switching the
gas sampling from the respiratory circuit to ambient air. The automatic zeroing is
performed after startup and 1 to 3 times per day and it takes less than 3 seconds.
• During zeroing, if ISA’s exhaust gas is returned to the patient circuit, the returned
gas level will be different from the gas level at the sampling site.
Calibration intervals for ISA CO2 • When the message “CO2 calibration is required” is displayed
sensor • When an offset in gas readings is discovered (0-offset)
Art. no.: 0-48-0227 Rev.: g
Zeroing procedure 1. Select the menu CO2 > ETCO2 and then the menu item “Perform zeroing”. The
green LED on the ISA sensor is blinking and the Zeroing process is displayed
on the DEFIGARD/PHYSIOGARD Touch 7.
2. When the green LED on the sensor stops blinking, the calibration is finished.
3. Check the etCO2 curve in the display to see if the connections have been made
correctly and if the etCO2 value is in the expected range. The curve rises during
expiration.
Page 73
4 Monitoring
4.12 Registering events DEFIGARD/PHYSIOGARD Touch 7
Data (ECG, automatic and manual events) can be displayed on a PC by use of the
Schiller data reviewing Software.
Page 74
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide View Trend, R-ECG and Screenshots 4.13
Page 75
4 Monitoring
4.13 View Trend, R-ECG and Screenshots DEFIGARD/PHYSIOGARD Touch 7
To print a screenshot, tick the box on the right and click on "next".
Several screenshots can be selected and printed.
The screenshot is available for printout only when the icon has switched from
camera to camera + printer
The printout files may take some time to be generated.
Page 76
Monitoring 4
DEFIGARD/PHYSIOGARD Touch 7 User guide Transmission 4.14
4.14 Transmission
Various data are available for transmission via several communication channels e.g.
GSM/3G, Wi-Fi, USB-Ethernet and USB storage.
To change the transmission media select the transmission icon Wifi or GPRS and
select menu Communication media. Select Wifi or GPRS and the corresponding
search for icon will be displayed on the top right status bar.
Network
Ensure that a transmission line is connected to the device and that the required
Menu configurations in the Control panel menu have been made.
Screenshots
Stop Intervention
00547_160318_103611
Post-Intervention
Transmission in progress
3. Press the button next and select the desired transmission channel (GSM/3G, Wifi,
USB/Ethernet or USB storage).
4. The transmission icon on the top right status bar shows the progress of the trans-
Transmission failed mission.
5. Select the transmission icon to open the Transmission list.
Art. no.: 0-48-0227 Rev.: g
Transmission successful
No connection to the WLAN
or GPRS transmission
channel. Transmission only
to USB stick possible
If transmission of the data fails, the ECG/Screenshot file can be re-sent via the Menu>
ECG or Screenshots
Page 77
5 Defibrillation
5.1 Application guidelines and safety notes DEFIGARD/PHYSIOGARD Touch 7
5 Defibrillation
This chapter applies only to the DEFIGARD® Touch 7.
Equipment damage! Sensors and devices that are not defibrillation proof must
be disconnected from the patient before a shock is triggered.
Page 78
Defibrillation 5
DEFIGARD/PHYSIOGARD Touch 7 User guide Application guidelines and safety notes 5.1
The user is committed to verify the prerequisites for the use of the AED by
checking for lack of consciousness, lack of breathing and lack of circulatory
signs using the ABCD system (BLS algorithm).
The device must only be used if the following symptoms are found:
– non-responsive
– no respiration
– no pulse
If, in the course of treatment, a patient spontaneously regains consciousness, a
defibrillation shock that may have been advised just before must not be
delivered.
To ensure correct analysis of the heart rhythm, the patient must lie as still as
possible and must not be touched, as artefacts may otherwise lead to incorrect
analysis results.
If the ECG signal changes such that the shock is not recommended, the shock
delivery is automatically blocked in the AED mode.
Art. no.: 0-48-0227 Rev.: g
Page 79
5 Defibrillation
5.1 Application guidelines and safety notes DEFIGARD/PHYSIOGARD Touch 7
Defibrillation on neonates
When using the defibrillator on neonates, follow the local guidelines.
Follow the energy setting for infants and small children as described above.
The automatic energy setting for neonates is the same as for children.
When paediatric pads are used, the patient type setting Adult or Child/Neonate on
the screen does not overrule the energy setting: when paediatric pads are connected
to the device, the energy setting is always paediatric.
Paediatric Patient type Electrode/energy setting
electrode information
50/50/50Joule
If no children electrodes are available, adult electrodes can be used. When adult pads
are used, the patient type setting “Child/Neonate” on the screen does overrule the
energy setting Adult to “Child/Neonate”.
Adult Patient type Electrode/energy setting
electrode information
150/200/200 Joule
50/50/50Joule
Art. no.: 0-48-0227 Rev.: g
2 50/50/50Joule
Neonate
Page 80
Defibrillation 5
DEFIGARD/PHYSIOGARD Touch 7 User guide General function 5.2
Page 81
5 Defibrillation
5.2 General function DEFIGARD/PHYSIOGARD Touch 7
Page 82
Defibrillation 5
DEFIGARD/PHYSIOGARD Touch 7 User guide General function 5.2
In the AED operational mode, the alarm system remains active in the same state as
in the monitoring operational mode.
Text instruction
30 CHEST COMPRESSIONS
THEN 2 RESCUE BREATH
Action picture
Opening CPR menu to activate/deactivate metronome and activating
the Schiller feedback advisory system when using the Schiller
Analyse soft key
LifePoint sensor or FreeCPR (based on impedance).
Art. no.: 0-48-0227 Rev.: g
Switching from the AED mode to Monitoring mode must be confirmed with Yes
. This depends on the device’s configuration (see 12.6.1 General
configuration)
Page 83
5 Defibrillation
5.2 General function DEFIGARD/PHYSIOGARD Touch 7
Page 84
Defibrillation 5
DEFIGARD/PHYSIOGARD Touch 7 User guide Manual Defibrillation Using Pads 5.3
Only use the pads up to their expiration date. Please note that the indicated
expiration date only applies if the vacuum pack is intact.
The pads are pre-gelled, so there is no need to use extra contact agent.
Do not reuse the pads.
Adult electrodes The adult electrodes with the blue connector are used for adults and children from
25 kg.
The adult electrode can be used for children when the patient type is set to “Child”
(see 5.1.2 Defibrillating children/neonates page 80).
Paediatric electrodes The paediatric electrodes with the yellow connector are used for children
weighing less than 25 kg.The energy setting is automatically reduced (default 50
Joule) with the paediatric electrodes. The default can be set in the device’s
configuration see 12.6.3 Defibrillator)
Art. no.: 0-48-0227 Rev.: g
Page 85
5 Defibrillation
5.3 Manual Defibrillation Using Pads DEFIGARD/PHYSIOGARD Touch 7
Good contact between the skin and the adhesive electrodes must be ensured.
Suntan oil, sand or salt reduce the adhesive quality.
The applied pads must have good contact with the patient's skin, and air bubbles
under the pads must be avoided. To do so, stick on one end of the pad then
smooth it out to the other end.
The safety distance between the two electrodes should be approx. 3 cm.
1. Clean and dry the application points for the electrodes (see Fig. 5.2 Adult elec-
trode application sites page 86/Fig. 5.3 Electrode application sites for children
weighing 25 kg or more page 86). Only clean the skin by vigorously rubbing it with
a dry cloth.
2. Apply one electrode above the right nipple. Do not apply it on the clavicle (une-
ven).
3. Apply the other electrode slantwise below the left breast as illustrated in Fig. 5.2
Adult electrode application sites page 86/Fig. 5.3 Electrode application sites for
children weighing 25 kg or more page 86).
Fig. 5.2 Adult electrode application sites 4. Make sure that the connections are positioned on the outside so that the cables
do not hinder cardiopulmonary resuscitation (CPR).
1. Clean and dry the application points for the electrodes (see Fig. 5.4 Application
sites for children less than 25 kg page 86). Only clean the skin by vigorously rub-
bing it with a dry cloth.
Art. no.: 0-48-0227 Rev.: g
2. Apply one electrode on the left of the right nipple as illustrated in Fig. 5.4 Applica-
tion sites for children less than 25 kg page 86
3. Apply the second electrode on the back on the same level as the chest electrode
as illustrated in Fig. 5.4 Application sites for children less than 25 kg page 86.
Make sure that the connections are positioned on the outside so that the cables do not
hinder cardiopulmonary resuscitation (CPR).
Page 86
Defibrillation 5
DEFIGARD/PHYSIOGARD Touch 7 User guide Manual Defibrillation Using Pads 5.3
1. Alternately press the electrodes/pads down firmly and check when the message
disappears. Carefully press that pad onto the patient's skin once again.
If the message does not disappear,
2. remove both defibrillation electrodes
3. wipe rests of contact agent off with a cloth
4. shave both application areas to remove the uppermost layer of skin
5. apply new defibrillation pads to these points.
Art. no.: 0-48-0227 Rev.: g
Page 87
5 Defibrillation
5.3 Manual Defibrillation Using Pads DEFIGARD/PHYSIOGARD Touch 7
Page 88
Defibrillation 5
DEFIGARD/PHYSIOGARD Touch 7 User guide Synchronised defibrillation 5.4
The synchronized mode (1) is manually activated (Sync ON/OFF). Depending on the
factory setup, the synchronized mode stays activated after delivering the shock (Sync
after sync shock =Yes) or switches back to unsynchronized shock (Sync after sync
shock = No). The current setting must be communicated to the user.
1
The default setting is “Sync after sync shock = No”:
the manual activated synchronized mode will be deactivated after delivering a
synchronized shock. To deliver a second synchronized shock, it is important to
activate it again.
If the admin setting is “Sync after sync shock = YES”:
the manual activated synchronized mode is maintained after delivering a
synchronized shock. To deliver a unsynchronized shock, it is important to
Metronome CPR Guide Event
deactivate it again.
Art. no.: 0-48-0227 Rev.: g
Page 89
5 Defibrillation
5.4 Synchronised defibrillation DEFIGARD/PHYSIOGARD Touch 7
Be aware that after initiation of the shock, the actual shock will be released with
the next trigger signal (QRS) derived from the ECG. This may lead in a shock
delivery delay time of 30 second.
Page 90
Defibrillation 5
DEFIGARD/PHYSIOGARD Touch 7 User guide Synchronised defibrillation 5.4
Be aware that after initiation of the shock, the actual shock will be released with
the next trigger signal (QRS) derived from the ECG. This may lead in a shock
delivery delay time of 30 second.
11. After the shock is delivered, monitor the patient and the ECG signal.
If the default setting is “Sync after sync shock = No” the synchronized
defibrillation mode is switched back to OFF after delivering the shock.
Page 91
5 Defibrillation
5.5 Semi-automated defibrillation DEFIGARD/PHYSIOGARD Touch 7
• In the AED operational mode, the patient is not under monitoring conditions.
• The switched off device can be started directly in AED mode by pressing the AED
button .
Switch to AED mode by pressing the AED key and confirm with the check box.
When the AED mode starts, the spoken and visual instructions for the defibrillation are
issued and the analyses will be running automatically as soon as the pads are applied.
Closely follow the instructions.
Switching from the AED mode to Monitoring mode must be confirmed with Yes
.
Metronome CPR Guide ECG curve Analyse
Art. no.: 0-48-0227 Rev.: g
Page 92
Defibrillation 5
DEFIGARD/PHYSIOGARD Touch 7 User guide Semi-automated defibrillation 5.5
The sequencing of AED instructions might be very fast and could cause
confusion to the user because:
The “Anteriority Analyse” feature pre-analyses the heart rhythm before the
actual analysis. This feature can substantially reduce the duration of the
analysis.
a.When paediatric electrodes are used, CPR is carried out in the ratio of 15:2 if 2 rescuers are on the spot, otherwise 30:2.
A “continuous compressions" option is also available (i.e. no rescue breaths)
Art. no.: 0-48-0227 Rev.: g
Page 93
5 Defibrillation
5.5 Semi-automated defibrillation DEFIGARD/PHYSIOGARD Touch 7
Step 2 Analysis
6. The analysis starts automatically when the electrodes are detected.
7. You are prompted not to touch the patient any more.
8. The analysis key can be pressed any time during CPR to start a new analysis.
If the device detects ventricular fibrillation or ventricular tachycardia with a heart rate
exceeding 150 pulse/min, Step 3 shock delivery follows; otherwise continue with Step
4, Cardiopulmonary resuscitation, page 95.
Fig. 5.9 Analysis
Page 94
Defibrillation 5
DEFIGARD/PHYSIOGARD Touch 7 User guide Semi-automated defibrillation 5.5
The CPR duration may vary according to country-specific standards (see page 110
Defibrillator ERC Protocol).
Art. no.: 0-48-0227 Rev.: g
Page 95
5 Defibrillation
5.6 CPR Guide DEFIGARD/PHYSIOGARD Touch 7
COMPRESSION
RECOIL good
MESSAGE
100 90 120
Page 96
Defibrillation 5
DEFIGARD/PHYSIOGARD Touch 7 User guide CPR Guide 5.6
5.6.2 FreeCPR
• The FreeCPR measures the compression rate based on the impedance
measurement by the defibrillation electrodes.
Continuous
Page 97
5 Defibrillation
5.7 Defibrillator Technical Messages DEFIGARD/PHYSIOGARD Touch 7
• A shock that is not delivered within Do not exceed the time of 20 sec-
Internal discharge duration onds till releasing the shock
T.DEFI09 the specified duration causes an in-
too long
ternal discharge. Contact technical service
Page 98
Pacemaker 6
DEFIGARD/PHYSIOGARD Touch 7 User guide Pacemaker Function 6.1
6 Pacemaker
6.1 Pacemaker Function
The pacemaker is the module for external transcutaneous stimulation of the heart.
The pacemaker offers two modes of operation, demand and fixed-rate pacing. In
demand mode, the pacemaker requires an ECG signal for synchronisation.
The same, large adhesive electrodes used for defibrillation are also employed for
pacing. They ensure good electrical contact with the skin. These electrodes and a 20
ms square-wave pulse reduce painful muscle contractions provoked by excessive
current density.
Pacer rate, pulse width and current are checked when the device is turned on and
during operation; therefore, a functional test of the pacemaker module is not
necessary.
The demand mode is the recommended pacing mode when the patient is at risk of
developing bradycardia or even asystole as a result of a critical event. As the
pacemaker function is controlled by the patient's ECG, the harmful competition
between intrinsic and external stimulation, which could induce ventricular fibrillation,
is excluded.
Art. no.: 0-48-0227 Rev.: g
Page 99
6 Pacemaker
6.2 Safety Notes DEFIGARD/PHYSIOGARD Touch 7
All electrical devices that deliver energy to patients in any form or have an electrically
conductive connection to the patient are a potential source of danger.
As the user is responsible for the safe application of the devices, observance of the
instructions given in the user manual and of the guidelines below is of utmost
importance.
Pacemakers must only be used under the supervision of trained, qualified and
authorised staff.
Observe the user guide for the pacemaker's operation.
The patient must not be left unattended during pacing.
It is assumed that the patient's ECG and plethysmogram is being monitored to
be able to assess the effect of pacing.
When positioning the patient, take care that no electrically conductive
connections exist between the patient and earthed metal parts (puddles of
Art. no.: 0-48-0227 Rev.: g
water, for instance, are capable of conducting the electrical current). Although
the pacer current output is required to be floating, this is an additional safety
precaution to ensure that the pacemaker current pulse flows only between the
pacemaker electrodes.
Set all values for the pacemaker to position 0, or the lowest value.
Position stationary pacemakers close to the patient.
After each defibrillation, check that the pacemaker is functioning properly.
Page 100
Pacemaker 6
DEFIGARD/PHYSIOGARD Touch 7 User guide Guidelines for the Application of External Pacemakers 6.3
• The same adhesive electrodes used for defibrillation are also employed for pacing.
The electrodes are designed for:
A detailed application of electrodes is given in section 5.3.1 Applying the adult and
paediatric electrodes page 85.
Anterior-posterior placement
1. Apply the dorsal electrode (+) to the left scapular area and the precordial elec-
trode (-) near the left lower sternal edge.
2. Connect the pads to the device.
If the dorsal electrode cannot be used, apply anterior-anterior placement.
Anterior-anterior placement
1. Apply the "+" electrode on the right side below the clavicle and the "-" electrode
to the left of the axillary line on a level with the 5th intercostal space so they do not
hinder heart massage.
2. Connect the pads to the device.
1. Alternately press the electrodes/pads down firmly and check when the message
disappears. Carefully press that pad onto the patient's skin once again.
If the message does not disappear,
2. remove both defibrillation electrodes
3. wipe rests of contact agent off with a cloth
4. shave both application areas to remove the uppermost layer of skin
5. apply new defibrillation pads to these points.
Page 101
6 Pacemaker
6.4 Start-up of the Pacemaker DEFIGARD/PHYSIOGARD Touch 7
In order to be able to operate the pacemaker, the following conditions must be met:
Page 102
Pacemaker 6
DEFIGARD/PHYSIOGARD Touch 7 User guide Start-up of the Pacemaker 6.4
The pacemaker default mode at switchover is “Demand” mode; the “Fix” mode has
to be selected manually.
HR
Type of used
electrodes
Frequency
Fixed
3
Current
Demand
4. When the pacemaker is running, press Close (4) or switch to monitoring with the
monitoring key.
In this case, the pacemaker values are displayed as small measurement field (1) at
the top right and the curve field shows again all curves.
Art. no.: 0-48-0227 Rev.: g
Page 103
6 Pacemaker
6.4 Start-up of the Pacemaker DEFIGARD/PHYSIOGARD Touch 7
Frequency
Fixed
Current
Demand
2
3
Shock hazard!
Pacing is started immediately when the pacemaker is switched ON and the
current is set.
Never touch the pads or the patient's body near the pads while the pacemaker
is in use.
Page 104
Pacemaker 6
DEFIGARD/PHYSIOGARD Touch 7 User guide Start-up of the Pacemaker 6.4
Frequency
Fixed
Current
Demand
2
3
Shock hazard!
Pacing is started immediately when the pacemaker is switched ON and the
current is set.
Never touch the pads or the patient's body near the pads while the pacemaker
is in use.
Page 105
7 Finishing the Therapy
6.4 Start-up of the Pacemaker DEFIGARD/PHYSIOGARD Touch 7
Adhesive electrodes – Carefully remove the electrodes from the patient's skin.
– Discard the disposable pads immediately after use to prevent their reuse (hos-
pital waste).
– Clean the device, ECG cables and sensors as described in section 10.6.2 page
119).
Page 106
Intervention summary 8
DEFIGARD/PHYSIOGARD Touch 7 User guide Start-up of the Pacemaker 6.4
8 Intervention summary
In order to document the intervention, the intervention data is saved.
The information can be read and displayed with the Schiller reviewing software or
viewed directly on the device
Menu
Trends
R-ECG
Screenshots
Stop Intervention
00547_160318_103611
Post-Intervention
• Power on
• Start of analysis
• Analysis result
• Defibrillator charging
• Defibrillation shock
• Internal discharge
• Switchover to manual operation
• Electrode alarm
Art. no.: 0-48-0227 Rev.: g
Page 107
8 Intervention summary
8.1 Post-intervention DEFIGARD/PHYSIOGARD Touch 7
8.1 Post-intervention
Exiting this menu is only possible by switching off-on the device.
1. To review the intervention data directly on the device, go to the main menu and
select “Post-intervention.
Menu 2. Stop the patient monitoring. The Post-Intervention menu is displayed.
3. Select “Memory” to display the intervention list.
4. Select desired intervention.
Menu 5. For each intervention you can review, print or send the following data:
Post Intervention
“Post-intervention.
2. Stop the patient monitoring. The Post-Intervention menu is displayed.
3. Select Transmit/Clear the memory to send all intervention data via Network or di-
rect to USB memory stick.
8.1.3 Autotest
An autotest can be executed after a finalised intervention to check the performance
of the device. Additionally, the autotest report can be viewed or sent via Network or
directly to a USB memory stick.
Page 108
Main Menu 9
DEFIGARD/PHYSIOGARD Touch 7 User guide General setup 9.1
9 Main Menu
9.1 General setup
For the monitoring of vital parameters, physiological alarm thresholds are preset in the
DEFIGARD/PHYSIOGARD Touch 7, which are activated when the device is turned
on. The operator-defined thresholds (wide/narrow) can be set in the respective menus
(see page 40, section 4.3);
---
Adult Off
HR
Menu
Choose another view
NIBP
Trends
R-ECG
Screenshots
Stop Intervention
00547_160318_103611
Page 109
9 Main Menu
9.1 General setup DEFIGARD/PHYSIOGARD Touch 7
Page 110
Main Menu 9
DEFIGARD/PHYSIOGARD Touch 7 User guide General setup 9.1
Page 111
10 Maintenance
10.1 Maintenance interval DEFIGARD/PHYSIOGARD Touch 7
10 Maintenance
10.1 Maintenance interval
Note
The unit must be serviced on a regular basis. The test results must be recorded and
compared with the values in the accompanying documents.
The following table indicates the intervals and responsibilities of the maintenance
work required. Local regulations in your country may stipulate additional or different
inspection intervals and tests.
Page 112
Maintenance 10
DEFIGARD/PHYSIOGARD Touch 7 User guide Maintenance interval 10.1
Accessories shelf life Power battery (approx. 5 years), safety cell (approx. 7 years), button cell (approx. 10
years) and electrodes (approx. 2 years), see expiring date on the battery or electrodes
pouch. EtCO2 accessories see expiring date on the packaging.
Art. no.: 0-48-0227 Rev.: g
Page 113
10 Maintenance
10.2 Functional test DEFIGARD/PHYSIOGARD Touch 7
– The battery indicator is off when the battery is fully charged - the full bat-
tery symbol is displayed. The charging process can be reactivated and
2. Use the button “-” to set the energy to 2 joule; then use the button “+” to set the
energy to 4 joule.
3. Press the Charge button. Device is charging. Shock key is lit.
4. Press the Shock key - a safety discharge is triggered.
5. Press the AED key - spoken instructions are issued and the pads connector LED
is flashing.
Page 114
Maintenance 10
DEFIGARD/PHYSIOGARD Touch 7 User guide Functional test 10.2
4. If message “Press shock button” appears, press the button to continue and
finalizing the test.
Previous tests are listed in the sub-menu “Review/send previous tests”.
Heart rate Perform the functional test according to section 4.4.5 page 45 and verify the heart
rate with the measured pulse rate of the SpO2.
SpO2 This test is performed on a volunteer (finger measurement; section 4.6.3, page
52).
NIBP This test is performed on a volunteer (arm measurement; section 4.7.1, page 57)
Manometer Test
See technical manual 0-48-0245_NT_DGTouch7_ANG
IBP This test only includes the connection between the sensor and the Touch 7, and the
Zeroing function.
1. Connect the sensor to the Touch 7 according to section 4.8.1 page 59.
2. Perform a “zeroing according to section 4.8.4 page 61.
3. Zeroing is shown on the display.
CO2 Mainstream Perform the functional test according to section 4.10.3 page 65.
CO2 Sidestream Perform the functional test according to section 4.11.2 page 71.
Alarm volume Check during the following tests that the alarm sound is higher than 65 dB.
Heart rate 1. Start the ECG monitoring (see section 4.4.5, page 45).
2. Set the alarms with the narrow quick set function (see section 4.3, page 40).
3. When the measured value exceeds the alarm thresholds, an alarm is issued.
4. Reset the alarm limits to their original values.
Art. no.: 0-48-0227 Rev.: g
NIBP 1. Start the NIBP monitoring (see section 4.7.1, page 57).
2. Set the NIBP alarm limits below/above the measured values and take a new
measurement.
3. When the measured value exceeds the alarm thresholds, an alarm is issued.
4. Reset the alarm limits to their original values.
CO2 1. Start the CO2 monitoring according to section 4.10.3 page 65 or 4.11.2 page 71
2. Set the alarms with the narrow quick set function (see section 4.3, page 40).
3. When the measured value exceeds the alarm thresholds, an alarm is issued.
Page 115
10 Maintenance
10.2 Functional test DEFIGARD/PHYSIOGARD Touch 7
If the device does not behave as described in this user guide, there is an error that
must be repaired by the after-sales service.
Page 116
Maintenance 10
DEFIGARD/PHYSIOGARD Touch 7 User guide Update Software 10.3
This function is only used for updating the software.The software can be updated via
Wifi (update Server) or USB interface (memory stick).
Update 1. Switch on the device and make sure that it is connected to the DC supply or that
the battery is charged sufficiently. The device must not switch off during the up-
date!
2. Select the parameter Software update and start the update by selecting the de-
sired update source. During update, a progress bar is displayed.
3. As soon as the update is finished, the device switches off.
4. Switch the device on again and enter the Menu > Control Panel > Software up-
date > Current software version to verify that the software has been installed.
Art. no.: 0-48-0227 Rev.: g
Page 117
10 Maintenance
10.4 Maintenance interval of the batteries DEFIGARD/PHYSIOGARD Touch 7
Page 118
Maintenance 10
DEFIGARD/PHYSIOGARD Touch 7 User guide Cleaning 10.5
10.5 Cleaning
Cleaning removes dust, dirt and stains; however, this does not constitute a
disinfection. Use commercially available detergents intended for clinics, hospitals
and practices.
10.5.1 Detergents
Please refer to the manufacturer's information regarding the detergents.
• Ethyl alcohol
• Acetone
• Hexane
• Abrasive cleaning powder
• Plastic-dissolving products
Art. no.: 0-48-0227 Rev.: g
Page 119
10 Maintenance
10.6 Disinfection DEFIGARD/PHYSIOGARD Touch 7
10.6 Disinfection
Use commercially available disinfectants intended for clinics, hospitals and
practices to disinfect the device.
Wipe disinfection removes certain bacteria and viruses. Please refer to the
manufacturer's information.
10.6.1 Disinfectant
• Organic solvents
• Ammonia-based detergent
• Abrasive cleaning agents
• 100% alcohol, Virex, Sani-Master
• Sani-Cloth®, Ascepti® or Clorox® wipes
• HB Quat®
• Conventional cleaner (e.g. Fantastic®, Tilex® etc.)
• Conductive solution
• Solutions or products containing the following ingredients:
– Acetone
– Ammonium chloride
– Betadine
– Chlorine, wax or wax compound
– Ketone
– Sodium salt
Page 120
Maintenance 10
DEFIGARD/PHYSIOGARD Touch 7 User guide Disposal at the end of the device's useful life 10.7
Remove the battery and close the cover before cleaning. See section 3.2
Switching off and disconnecting from the external DC supply page 31.
Do not immerse the unit nor the cable or sensors in liquid and do not sterilise
them!
Do not apply tension to the sensor cable.
Do not use aggressive cleaners.
Do not use any phenol-based agents or peroxide compounds for cleaning.
Reusable sensors must be treated as biologically dangerous material after
usage and sterilised according to the manufacturer's instructions.
Observe the manufacturer's notes when cleaning the sensors and cables.
1. Disconnect the device from the mains and remove the plug and sensors.
2. Wipe the equipment, cable and sensors with a dampened cloth and a mild clean-
ing solution. The manufacturer recommends using 70% alcohol.
3. Dispose of single-use sensors and protective coverings according to the relevant
regulations.
Notes on the cleaning and disinfection
NIBP cuff The manufacturer recommends using 70% alcohol to clean and disinfect the NIBP
cuff and tube.
SpO2 sensor The manufacturer recommends using 70% alcohol to clean the cable and sensor. Dry
the sensor before reuse.
ECG cable The cable can be wiped with a mild cleaning agent or with 70% alcohol.
CO2 sensors The IRMA probe can be cleaned using a cloth moistened with ethanol or isopropyl
alcohol (< 70 %).
The ISA sidestream gas analyzers and the Nomoline Adapter may be cleaned using
a cloth moistened (not wet) with max 70% ethanol or isopropyl alcohol.
To prevent cleaning liquids and dust from entering the ISA gas analyzer through its
sampling gas inlet connector, keep the Nomoline Family sampling line fitted while
cleaning the analyzer.
If no such collection point or recycling centre is available, you can return the unit to
your distributor or the manufacturer for proper disposal. In this way, you contribute to
the recycling and other forms of utilisation of old electrical and electronic equipment.
Improper disposal harms the environment and human health due to the presence of
dangerous substances in electrical and electronic equipment.
Page 121
10 Maintenance
10.8 Inspection and Checklist Tables DEFIGARD/PHYSIOGARD Touch 7
10.8.1 Monthly
• Functional test charging capacitor with maximum energy. This is done with the
Auto test function (see section 10.2.4)
Month Date Periodic test results OK Periodic test results NOT OK
1 o o
2 o o
3 o o
4 o o
5 o o
6 o o
Art. no.: 0-48-0227 Rev.: g
7 o o
8 o o
9 o o
10 o o
11 o o
12 o o
Page 122
Maintenance 10
DEFIGARD/PHYSIOGARD Touch 7 User guide Inspection and Checklist Tables 10.8
Page 123
10 Maintenance
10.9 Error Detection DEFIGARD/PHYSIOGARD Touch 7
Press and hold the green button until the device has switched off. Then
switch on again.
Device cannot be switched • Software hangs Keep the green button pressed for at least 10 seconds.
off • The device is defective Replace device
Battery is not being • Temperature in the device or Let device cool down, if possible; charging is continued
charged battery too high once the temperature has reached an acceptable level. Art. no.: 0-48-0227 Rev.: g
Page 124
Maintenance 10
DEFIGARD/PHYSIOGARD Touch 7 User guide Error Detection 10.9
Page 125
10 Maintenance
10.9 Error Detection DEFIGARD/PHYSIOGARD Touch 7
It can be deducted from the table that portable RF telecommunication devices must
not be used within a radius of 3 m from the device and its cables.
The user can take the following measures to prevent electromagnetic interferences:
• Increase distance to the source of interference.
• Turn the device to change the angle of radiation.
• Connect the device to a different mains connector.
• Only use original accessories (especially patient cables)
• The device should not be used adjacent to or stacked with other equipment.
Art. no.: 0-48-0227 Rev.: g
Page 126
SCHILLER Charging Unit CS-1 11
DEFIGARD/PHYSIOGARD Touch 7 User guide Battery Charging Options 11.1
• Batteries can be removed and charged using the optional charging unit SCHILLER
CS-1 (see following).
• The DEFIGARD/PHYSIOGARD Touch 7 batteries are also charged when the
DEFIGARD/PHYSIOGARD Touch 7 is connected to the external power supply.
The charger has double contacts and a battery can be inserted in either way.
Page 127
11 SCHILLER Charging Unit CS-1
11.3 Control Panel DEFIGARD/PHYSIOGARD Touch 7
Power connected
indicator
Calibration button
LED Function
No LEDs lit - No battery inserted.
Constant display for 5 seconds - When a battery is first
inserted, one, two or three LEDs are lit for 5 seconds.
This indicates the battery charge state (1 LED = 1/3
capacity, 2 LEDs = 2/3 capacity and 3 LEDs = 100%
capacity).
LEDs are flashing in sequence (left to right)- After 5
seconds of a battery being inserted, the charge
sequence starts.
All LEDs lit - battery fully charged.
LEDs are flashing in sequence (right to left) - battery
being calibrated (see page129).
LEDs blink two/one in sequence - faulty battery.
Page 128
SCHILLER Charging Unit CS-1 11
DEFIGARD/PHYSIOGARD Touch 7 User guide Battery Calibration 11.4
The calibration cycle takes approximately 2.5 - 5 hours to complete - the full charge
cycle (after full discharge) takes approximately 2.5 hours. During the calibration
process:
If for any reason the battery cannot be calibrated, the LED above the CAL key is
flashing. This indicates that the battery cannot be calibrated and the battery should
not be used any longer.
The calibration process can be stopped at any time, by again pressing the Cal key.
Art. no.: 0-48-0227 Rev.: g
Page 129
11 SCHILLER Charging Unit CS-1
11.5 Input and Output Supplies DEFIGARD/PHYSIOGARD Touch 7
2 3 4 5 6 7 1
Page 130
Technical Data 12
DEFIGARD/PHYSIOGARD Touch 7 User guide System data 12.1
12 Technical Data
Data refer to standard testing conditions.
Technical data about the defibrillation (chapter 12.2) applies only to the
DEFIGARD® Touch 7.
Protection case IP 55
Power battery
Battery type Lithium/ion 11.1 V, 4.65 Ah, 51.6 Wh
Autonomy 100 shocks with maximum energy or >6 hour monitoring
Charging time 90 %: 2 hours after full discharge and device switched off
Safety primary cell Ensures continued monitoring for approx. 30 seconds when replacing the power
battery
Art. no.: 0-48-0227 Rev.: g
Environmental conditions
For operation • 0 ºC ... 40 ºC relative humidity at 15 - 95 % (non condensing)
Atmospheric pressure 700...1060 hPa
• If higher or lower temperatures prevail during use, a limited operation time of up
to 1 hour is possible, if device has been stored previously at room temperature.
See next page “environmental conditions for transient operation”
Page 131
12 Technical Data
12.1 System data DEFIGARD/PHYSIOGARD Touch 7
Environmental conditions Operation in NORMAL USE for a period not more than 20 min under the
For transient operation following environmental operating conditions:
• a temperature range of - 20 °C to + 50 °C;
• a relative humidity range of 15 % to 90 %, non-condensing, but not requiring a
water vapour partial pressure greater than 50 hPa.
Operation in NORMAL USE for a period of 1 hour under a temperature range of
- 10°C to + 50°C;
Environmental conditions
For Transport and storage • - 40 °C to + 5 °C without relative humidity control;
between uses • + 5 °C to + 35 °C at a relative humidity up to 90 %, non-condensing;
• > 35 °C to 70 °C at a water vapour pressure up to 50 hPa;
after having been removed from its protective packaging and subsequently
between uses.
Environmental conditions
Defibrillation electrodes
Storage • 0 ºC...50 ºC
Storage max. 10 days • -40 ºC...75 ºC
Display
Type • High-resolution colour LCD capacitive touch screen, protected by tempered glass
Dimensions • 7 “ (154 x 85.92 mm)
Alarm sound level 65 dBA for medium and high priority alarms
Interfaces USB
Page 132
Technical Data 12
DEFIGARD/PHYSIOGARD Touch 7 User guide System data 12.1
• Static discharges up to 15 kV
• Field strength up to 20 V/m in the radio frequency range of (80...2500 MHz, 5 Hz
modulated)
• Magnetic fields of 100 A/m, 50 Hz
Page 133
12 Technical Data
12.2 Defibrillation Waveform DEFIGARD/PHYSIOGARD Touch 7
Form • Biphasic pulsed defibrillation waveform with fixed physiological optimum phase
durations
• Near stabilisation of the emitted energy in function with the patient resistance
using pulse-pause modulation depending on the measured patient resistance
(duty cycle 80%).
Curve at an impedance of 100 Ω Printout: Current – left y-axis, (--- mean current calculated for each cycle)
Condenser voltage – right y-axis.
Current [A]
Voltage [V]
time [ms]
Duration [ms] 1.8 2.25 2.7 3.15 3.6 4.5 5.4 6.3 9.45 9.86
Second phase
Max. current [A] 36.6 28.5 23.5 20 17.1 14.3 11.8 9.9 6.6 6.5
Mean current [A] 18.6 16.4 14.7 12.6 11.5 9.4 8.2 7.1 4.9 4.9
Duration [ms] 2.25 2.700 2.700 3.150 3.150 3.600 3.600 4.050 4.050 4.050
Total shock duration [ms] incl. 0.5 ms of 4.55 5.45 5.9 6.8 7.25 8.6 9.5 10.85 13.55 14.4
pause between first and second phase.
Energy delivered [J] 196 192 189 188 182 187 182 179 184 177
Note: In the case of high patient impedance or some other specific usage cases, the energy delivered to the patient might be
lower than expected(e.g If patient impedance >= 150 Ohms, the rated energy level is set to 190J when 200J is selected)
Page 134
Technical Data 12
DEFIGARD/PHYSIOGARD Touch 7 User guide Defibrillation Waveform 12.2
Standard energy settings Deviation at 50 3 J or 15 % (the higher value is assumed)
AED
Adult 150/200/200 joules (configurable see page 149)
Paediatric 50/50/50 joules (configurable see page 149)
(automatic selected when the paediatric or adult electrodes are connected)
Manual mode
Adult 150 joules (configurable see page 149)
Paediatric 50 joules (configurable see page 149)
(default energy settings when starting in manual mode, adjustable anytime during
intervention)
Charging time for shock (Time used to charge the storage capacitor to the max. energy of 200 J in manual
mode)
Charge control and monitoring • Automatic shock recommendation of analysis in AED mode
• Direct via touch screen
• Display of selected energy
Shock delivery
Using key
Page 135
12 Technical Data
12.2 Defibrillation Waveform DEFIGARD/PHYSIOGARD Touch 7
Page 136
Technical Data 12
DEFIGARD/PHYSIOGARD Touch 7 User guide Defibrillation Waveform 12.2
[1]: The MIT-BIH Malignant Ventricular Arrhythmia The validation test set database used to establish compliance with the AHA
Database http://physionet.org/physiobank/data-
base/vfdb/
requirements [2] and the IEC Standards [3] is independent from the one used to
[2]: Automatic External Defibrillators for develop the rhythm recognition detector.
Public Access Defibrillation : The SAS validation test set contains the following ECG samples (see test sample size
Recommendations for Specifying and in Table 1):
Reporting Arrhythmia Analysis
Algorithm Performance, Incorporating • coarse ventricular fibrillation (VF) (>200 μV peak-to-peak amplitude)
New Waveforms and Enhancing • shockable ventricular tachycardia (VT hi) (HR >150 bpm, rushes that last more
Safety ; Circulation, 1997 ; 95 :1677- than 8s)
1682. • asystole (≤100 μV peak-to-peak amplitude)
• normal sinus rhythm (NSR) (PQRS-T waves visible, HR 40-100 bpm)
[3]: Standard IEC 2010 60601-2-4, ed 3. • other organized rhythm (N) (includes all rhythms except those in other listed
categories)
[4]: Shock advisory system with minimal delay trig-
gering after end of chest compressions: Accuracy For each test sample, in function of the expert rhythm annotation and the SAS
and gained hands-off time. Jean-Philippe Didon, decision (shock/no shock), an interpretation table is built and shows the true positive
Vessela Krasteva, Sarah Ménétré, Todor Stoyanov,
Irena Jekova, Resuscitation 82S (2011) S8-S15 (correct classification of a shockable rhythm), true negative (correct classification of a
non-shockable rhythm), false positive (non-shockable rhythm incorrectly classified as
[5]: Circulation. 2011; 124: A219, Resuscitation Sci- a shockable rhythm), false negative (shockable rhythm incorrectly classified as non-
ence Symposium Abstracts, Best Original Resusci-
tation Science Poster Session, Abstract 219: Com- shockable). Finally, the results of the detector performance are reported in terms of:
bination of Algorithms to Decrease Preshock Pause specificity-Sp (TN/(TN+FP)), true predictive value (TP/(TP + FP)), sensitivity-Se (TP/
for Automated External Defibrillators. Jean-Philippe
Didon, Irena Jekova, Sarah Ménétré, Todor Stoy-
(FN + TP)), false positive rate (FP/(FP + TN)).
anov, Vessela Krasteva.
The DEFIGARD® Touch 7 SAS when configured as “Analysis with anteriority to ON”
uses a combination of algorithms which are launched in two-stages [4-6] to deliver a
shock advisory decision at minimal delay after actual CC stoppage. The SAS
configured as “Analysis with anteriority to OFF” starts a chest compression-free VF
detection at an analysis request, without trying to optimize hands-off time. In both
configurations, the SAS does not continue analyzing after a shock advised decision
is reached.
Page 137
12 Technical Data
12.3 Pacemaker DEFIGARD/PHYSIOGARD Touch 7
The DEFIGARD® Touch 7 SAS test has been completed with a validation database
consisting of 2,475 couples of ECG and transthoracic Impedance Cardiogram (ICG)
from out-of-hospital cardiac arrest (OHCA) interventions, recorded with Automated
External Defibrillators (FredEasy, Schiller Medical SAS, France) used by the fire
brigade of Paris.
This supplementary test completes the validation of both SAS configurations and
provides performance fully in accordance with these summarized in Table 1. A report
of the global validation test results is available on request.
12.3 Pacemaker
Operating Modes • Demand
• Fixed frequency (FIX)
Stimulation pulse
Form Rectangle mono-phase with constant current source
Pulse duration 20 ms ± 5%
Pulse rate Configurable in steps of 40, 45, 50, 60, 70 ... 240 beats/min, ± 1.5%
Pulse current Configurable to 0 (pacemaker Off) and then from 10 ...200 mA, ± 10 % or 5 mA (the
higher value is applied)
Refractory period
• 340 ms 80 b/min
Signal connection • 240 ms >80 b/min
Readiness for operation Type BF, defibrillation-protected >5 kV
Immediately
Page 138
Technical Data 12
DEFIGARD/PHYSIOGARD Touch 7 User guide Technical data - monitoring 12.4
Heart rate
Range • 15 – 350 beats/min
Accuracy • ±10 % or 5 beats/min, whichever is greater
Suppression of large T-waves max. amplitude of T-wave according to IEC 60601-2-27 section 201.12.1.101.17:
0.8 mV
HR averaging method The heart rate calculation is done using a user-defined number of previous RR
intervals (minimum 4, maximum 16).
The RR intervals are reset and the heart rate is set to zero whenever an asystole
condition has been detected
Response time HR measurement Change from 80 to 120 beats per minute: 2.56 s
Duration until alarm is triggered in B1 and B2: 3 s (according to IEC specification 60601-2-27, 6.8.2.bb)
the case of tachycardia
ECG amplifier
Sampling rate 500 Hz
Art. no.: 0-48-0227 Rev.: g
Frequency range The ECG frequency range depends on the ECG cable, the ECG view and the
selected settings (see table next page).
Page 139
12 Technical Data
12.4 Technical data - monitoring DEFIGARD/PHYSIOGARD Touch 7
ECG amplifier band pass The band pass depends on the ECG source.
To pass distortion test according IEC 60601-2.25, Clause 201.12.4.107.1, use the 4
or 10 lead patient cable to set the ECG amplifier band pass to 0.05-150 Hz (see table
above).
Single pacemaker pulse • Duration 2.0ms, amplitude > 2mV and a overshoot of <0.25mV
• Duration 0.1ms, amplitude > 2mV and a overshoot of <0.8mV
Pacemaker pulse followed by an • Duration 2.0ms, amplitude between 4mV and 300mV
identical pulse within 150 ms • Duration 0.1ms, amplitude between 25mV and 300mV
followed by a QRS complex • Duration 2.0ms, amplitude between 4mV and 300mV
• Duration 0.1ms, amplitude between 25mV and 700mV without overshoot
• Duration 0.1ms, amplitude between 25mV and 300mV with overshoot
Pacemaker pulse followed by an • Duration 2.0ms, amplitude between 4mV and 400mV
identical pulse within 250 ms • Duration 0.1ms, amplitude between 25mV and 400mV
followed by a QRS complex • Duration 2.0ms, amplitude between 4mV and 300mV
• Duration 0.1ms, amplitude between 25mV and 700mV without overshoot
• Duration 0.1ms, amplitude between 25mV and 300mV with overshoot
Note: pacemaker signals from different pacemakers vary. In the case of cardiac
arrests or some arrhythmias, pacemaker signals might still be measured, especially
signals from pacemakers generating high amplitudes ( > 20mV) or overshoot.
Pacemaker patients need to be monitored very closely.
Art. no.: 0-48-0227 Rev.: g
Page 140
Technical Data 12
DEFIGARD/PHYSIOGARD Touch 7 User guide Technical data - monitoring 12.4
Connection Type CF
Measurement range
Adults(Child • Sys 30...255 mmHg, dia 15...220 mmHg
Neonate • Sys 30...135 mmHg, dia 15...110 mmHg
Zeroing Manual
12.4.5 Temperature
Sampling rate 2 Hz
Measuring range 15 °C to 45 °C
Resolution 0.1 °C
Page 141
12 Technical Data
12.4 Technical data - monitoring DEFIGARD/PHYSIOGARD Touch 7
Amplifier Masimo™
Measuring range
SpO2 0 % to 100 %
PP 25 to 240 /min
SpCO 0 to 99 %
SpMet 0 to 99.9 %
PI 0.02 to 20 %
Accuracya
SpO2 (no movement) • 60 to 80 % ± 3 % adults/children (10 -50 kg)/infants (3-20 kg)
• 70 to 100 % ± 2 adults/children/infants; ± 3 neonates
SpO2 (movement) 70 to 100 % ± 3 adults/children/infants/neonates
SpO2 (low perfusion) 70 to 100 % ± 2 adults/children/infants/neonates
PP (no movement) 25 to 240/min ± 3 digits adults/children/infants/neonates
PP (movement) 25 to 240/min ± 5 digits adults/children/infants/neonates
PP (low perfusion) 25 to 240/min ± 3 digits adults/children/infants/neonates
SpCO 1 to 40 % ± 3 adults/children/infants
SpMet 1 to 15 % ± 1 adults/children/infants/neonates
Resolution
SpO2 1%
PP 1 /min
SpCO 1%
SpMet 0.1 %
Connection Type CF
Page 142
Technical Data 12
DEFIGARD/PHYSIOGARD Touch 7 User guide Technical data - monitoring 12.4
a.
SpO2, SpCO and SpMet accuracy was determined by testing on healthy adult volunteers in the range of 60-100% SpO2, 0-40% SpCO, and 0-15%
SpMet against a laboratory CO-Oximeter. SpO2 and SpMet accuracy was determined on 16 neonatal NICU patients ranging in age from 7-135
days old and weighing between 0.5-4.25 kg. Seventy-nine (79) data samples were collected over a range of 70-100% SpO2 and 0.5-2.5%
MetHb with a resultant accuracy of 2.9% SpO2 and 0.9% SpMet.
The Masimo sensors have been validated for motion accuracy in human blood studies on healthy adult male and female volunteers with light to
dark skin pigmentation in induced hypoxia studies in the range of 70-100% SpO2 against a laboratory CO-oximeter and ECG monitor. This
variation equals plus or minus one standard deviation which encompasses 68% of the population.
The Masimo SET Technology has been validated for low perfusion accuracy in bench top testing against a Biotek Index 2 simulator and Masimo’s
simulator with signal strengths of greater than 0.02% and transmission of greater than 5% for saturations ranging from 70 to 100%. This vari-
ation equals plus or minus one standard deviation which encompasses 68% of the population.
The Masimo sensors have been validated for pulse rate accuracy for the range of 25-240 bpm in bench top testing against a Biotek Index 2 simu-
lator. This variation equals plus or minus one standard deviation which encompasses 68% of the population.
The following substances may interfere with pulse CO-Oximetry measurements:
- Elevated levels of Methaemoglobin (MetHb) may lead to inaccurate SpO2 and SpCO measurements
- Elevated levels of Carboxyhaemoglobin (COHb) may lead to inaccurate SpO2 measurements.
- Very low arterial Oxygen Saturation (SpO2) levels may cause inaccurate SpCO and SpMet measurements
- Severe anaemia may cause erroneous SpO2 readings.
- Dyes, or any substance containing dyes, that change usual blood pigmentation may cause erroneous readings.
- Elevated levels of total bilirubin may lead to inaccurate SpO2, SpMet, and SpCO readings.
Art. no.: 0-48-0227 Rev.: g
Page 143
12 Technical Data
12.4 Technical data - monitoring DEFIGARD/PHYSIOGARD Touch 7
The IRMA and ISA sensors are equipped with an automatic barometric pressure
compensation.
Accuracy The following specifications are valid for a dry gas at 22 ± 5°C and 1013 ± 40 hPa
(standard conditions).
Breath detection Adaptive threshold value, min. 1 vol% change in CO2 concentration
Respiration rate 0-150 /min. The respiration rate is displayed after three breaths and the average
value is updated after every breath.
Page 144
Technical Data 12
DEFIGARD/PHYSIOGARD Touch 7 User guide Technical data - monitoring 12.4
Page 145
12 Technical Data
12.5 Telecommunication GSM (option) DEFIGARD/PHYSIOGARD Touch 7
Standards • FCC, IC
• PTCRB
• R&TTE
• GCF
• RoHS/WEEE
• CE
• ANATEL
• KCC
• CCC
• JATE
Page 146
Technical Data 12
DEFIGARD/PHYSIOGARD Touch 7 User guide Device Configuration 12.6
• 0.5mm*
Curve thickness • 0.7mm Sets the thickness of the curves printed on the Bluetooth printer.
• 0.9mm
Page 147
12 Technical Data
12.6 Device Configuration DEFIGARD/PHYSIOGARD Touch 7
• Low
Selection of the overall sound level applied to technical and
Alarm sound level • Medium
physiological alarms
• High*
• False If this option is activated, the user will have the possibility to shut down
Audio off allowed
• True* totally sound alarming
12.6.2 ECG
Parameter Values Description
• 1p avg 1x6 10sec 12.5mms
• 2p 1x12 5sec 50mms Sets the PDF layout for the resting ECG
PDF Format • 1p 2x6 5sec 25mms* report. This layout will be used for the PDF
• 1p 4x3+1 2sec 25mms sent by Email
• 1p 1x12 10 sec 25mms
PDF encryption
• True If this option is activated, every Resting ECG
Encrypt PDF sent by the device will be password
• False* protected with the password specified in the
setting PDF password
Sets the wished password to protect the
PDF password • schiller
PDF of Resting ECG
R-ECG Low pass • 40Hz Sets the low pass filter frequency for the
filter • 150Hz* resting ECGTrue False*
Page 148
Technical Data 12
DEFIGARD/PHYSIOGARD Touch 7 User guide Device Configuration 12.6
12.6.3 Defibrillator
Parameter Values Description
Default energy for • 2, 4, 8, 15, 30, 50, 70, 90, Sets the energy which will be displayed by default when entering
adults in manual def. 120, 150*, 200 Joule manual defibrillation mode in adult mode
Default energy for • 2, 4, 8, 15, 30, 50*, 70, 90, Sets the energy which will be displayed by default when entering
children in manual def. Joule manual defibrillation mode in child mode
• True If this option is activated, the device remains in sync. mode after
Sync. after sync shock
• False* a synchronized shock in manual defibrillation
• 2, 4, 8, 15, 30, 50, 70, 90, Sets the energy which will be delivered for the first shock in AED
First shock for adults
120, 150, 200 Joule in adult mode
• 2, 4, 8, 15, 30, 50, 70, 90, Sets the energy which will be delivered for the second shock in
Second shock for adults
120, 150, 200 Joule AED in adult mode
• 2, 4, 8, 15, 30, 50, 70, 90, Sets the energy which will be delivered for the third shock in AED
Third shock for adults
120, 150, 200 Joule in adult mode
• 2, 4, 8, 15, 30, 50*, 70, 90, Sets the energy which will be delivered for the first shock in AED
First shock for children
Joule in child mode
Second shock for • 2, 4, 8, 15, 30, 50*, 70, 90, Sets the energy which will be delivered for the second shock in
children Joule AED in child mode
• 2, 4, 8, 15, 30, 50*, 70, 90, Sets the energy which will be delivered for the third shock in AED
Third shock for children
Joule in child mode
12.6.4 Display
Parameter Values Description
• False* Enables the analysis with anteriotity (part of the signal analysis is done
Anteriority Analysis
• True on the signal before the device mentions the start of the analysis).
• False If this option is activated, the analysis key will be displayed to allow
Analysis key
• True* additional manual analysis in AED mode.
Alarm on Vfib or • False* High priority alarm will be issued if Vfib or Vtach is detected during
Vtach detection • True* monitoring on both ECG cable and Defi pads.
Precognitive • False*
Not used at the moment, has no impact on the unit.
Analysis • True
Art. no.: 0-48-0227 Rev.: g
Page 149
12 Technical Data
12.6 Device Configuration DEFIGARD/PHYSIOGARD Touch 7
12.6.5 AED
Parameter Values Description
Display curve in • False
If enabled, ECG lead Defi is displayed in AED mode
AED • True*
• High
Metronome default behaviour in adult mode
AED voice level • Medium*
This behaviour can be changed during intervention on the device
• Low
• 30:2*
Metronome Metronome default behaviour in adult mode
• 15:2
behaviour adult This behaviour can be changed during intervention on the device
• Continuous Off
• 30:2
Metronome Metronome default behaviour in child mode
• 15:2*
behaviour child This behaviour can be changed during intervention on the device
• Continuous Off
• 100cpm*
Metronome rate • 110cpm Sets the frequency of the metronome
• 120cpm
• High
Metronome audio
• Medium* Sets the audio level of the metronome
level
• Low
• cm* Sets the unit in which the chest compression depth value will be
CPR depth unit
• inch displayed
• 1min
CPR cycle duration • 2min* Sets the duration of the CPR cycle
• 3min
12.6.6 ECG
Parameter Values Description
• 0.25mv
• 0.5mv Sets the default ECG curve amplitude, If Auto is selected, the
ECG curve
• 1mv* displayed amplitude will be automatically adapted depending on the
amplitude
• 2mv signal amplitude
• auto
• False*
ECG 16,7 Hz filter Not used at the moment, has no impact on the unit
• True
• Off
• Low*
Art. no.: 0-48-0227 Rev.: g
QRS sound level Sets the audio level of the QRS sound issued by the ECG
• Medium
• High
12.6.7 IBP
Parameter Values Description
IBP curve amplitude • 30, 60, 100, 300mmHg Sets the default IBP curve amplitude
Page 150
Technical Data 12
DEFIGARD/PHYSIOGARD Touch 7 User guide Device Configuration 12.6
12.6.8 NIBP
Parameter Values Description
Deflation rate • 3, 4, 5, 6, 7, 8, 9 mmHg/s Sets the cuff deflation rate
• mmHg*
NIBP unit Sets the unit in which the NIBP values will be displayed and stored
• kpa
Automatic cycles at • False* Automatic NIBP measurement cycle starts once a first measurement is
start • True initiated manually
12.6.9 SpO2
Parameter Values Description
Sets the integration time for the calculation of the displayed average
SpO2 average • 4, 6, 8, 10,12*,14, 16sec
value.
• Normal* Sets the measurement sensitivity.
SpO2 sensitivity • Automatic Probe Off De- Adaptive Probe Off Detection is optimised for the detection of Sensor
tection has come off, regardless of the signal quality.
• Off
• Low
SpO2 sound level Sets the audio level of the pulse sound
• Medium*
• High
12.6.10 Temp
Parameter Values Description
• Celcius* Sets the unit in which the temperature value will be displayed and
Temperature unit
• Fahrenheit stored
12.6.11 EtCO2
Parameter Values Description
Respiration curve
• 50*, 75, 100mmHg Sets the respiration curve amplitude to be displayed by default
amplitude
Art. no.: 0-48-0227 Rev.: g
• vol%
EtCO2 unit Sets the unit in which the EtCO2 value will be displayed and stored
• mmHg*
Page 151
12 Technical Data
12.6 Device Configuration DEFIGARD/PHYSIOGARD Touch 7
12.6.13 Event
Parameter Values Description
Enter an event name (for example a medication).
This event can be selected on the device in the events list during
Event (from 1 to 20) • Event(1 to 20) intervention. Once selected it is stored in the memory and flagged in
the intervention report
(20 customisable fields)
Authentication • False* Enables authentication for communication with the SMTP Server. This
required • True setting must be done according to SMTP Server requirements
Login - The login used for SMTP server authentication
Password - The password used for SMTP server authentication
Page 152
Technical Data 12
DEFIGARD/PHYSIOGARD Touch 7 User guide Device Configuration 12.6
12.6.16 Transmission
Parameter Values Description
If this option is activated, the device will automatically send over the
• False* media selected in configuration Transmission media during
Automatic R-ECG
intervention to the address specified for SEMA Server
transmission • True There will be no preview of the resting ECG on the device, after
acquisition, it will be automatically sent
The device is capable of transmitting automatically its memory after an
intervention using the media selected in Transmission media by
• When device plugged on automatic wake up, with the following scenario:
Automatic docking station - Never (Off)
intervention data
• At device power off - 10 minutes after the device has been shutted down (After device
transmission
• Off* power off)
- When a external power supply is detected (When device plugged on
docking station)
• Wi-Fi* The selected media will always be selected by default at manual start
Transmission media
• GSM/3G of the device.
during intervention
• USB/Ethernet This media can always be changed by the user during the intervention
Transmission media • Wi-Fi* The selected media will always be selected by default during automatic
by automatic wake • GSM/3G wake up of the device (automatic intervention data transmission,
up • USB/Ethernet automatic self test results transmission...)
12.6.17 Ethernet
Parameter Values Description
Sets the IP that will be used to test the connectivity of the device over
Ethernet. Usually, it's recommended to use either common DNS
Ethernet ping serve • 8.8.8.8
server(e.g.
8.8.8.8), or the public SEMA Server IP address
Art. no.: 0-48-0227 Rev.: g
Page 153
12 Technical Data
12.6 Device Configuration DEFIGARD/PHYSIOGARD Touch 7
12.6.18 WIFI
Parameter Values Description
SSID - SSID of the Wi-Fi Network that shall be used for data transmission
• WEP
• WPA
• WPA2* Type of encryption from the Wi- Fi Network that shall be used for data
Encryption type
• WPA-EAP transmission
• WPA2-EAP
• None
Security key of the Wi-Fi Network that shall be used for data
Security key -
transmission
Wi-Fi Login - Login used for EAP authentication
Wi-Fi Password - Password used for EAP authentication
Sets the IP that will be used to test the connectivity of the device over
WIFI. Usually, it's recommended to use either common DNS
Wi-Fi ping server -
server(e.g.
8.8.8.8), or the public SEMA Server IP address
12.6.19 GSM
Parameter Values Description
Sets the PIN code to unlock SIM card
PIN - It's recommended to either use the same PIN for all devices, or to
disable PIN on all SIM cards. Both are accepted by the device
Sets the APN of the M2M Internet provider
APN name -
Example: orange.m2m.spec or MATOOMA, or A1.net
APN port - Sets the APN port (if required by the APN)
APN user - Sets the APN user (if required by the APN)
APN password - Sets the APN password (if required by the APN)
APN extra
- If required by the APN, extra commands can be specified here
commands
Sets the IP that will be used to test the connectivity of the device over
GSM ping server 8.8.8.8 GSM. Usually, it's recommended to use either common DNS
server(e.g. 8.8.8.8), or the public SEMA Server IP address
12.6.20 SEMA
Parameter Values Description
Sets the IP address or the hostname of the SEMA Server
Art. no.: 0-48-0227 Rev.: g
Should the device be able to send data to SEMA over Internet (typically
through GSM), the public IP address or hostname must be specified
SEMA server -
and not the private
Example: 188.165.287.137
(public IP) and not 192.168.200.32 (private IP)
Sets the port with which SEMA Server is reachable. This port might be
different whether the device tries to connect with or without SSL
SEMA server port 8181 encryption
Example: By default, 8080 is used for HTTP and 8181 is used for
HTTPS
Page 154
Technical Data 12
DEFIGARD/PHYSIOGARD Touch 7 User guide Device Configuration 12.6
Page 155
12 Technical Data
12.7 Electromagnetic interferences DEFIGARD/PHYSIOGARD Touch 7
Interference testing IEC 60601 test level Conformity lev- Electromagnetic environment - explanations
Art. no.: 0-48-0227 Rev.: g
el
Page 156
Technical Data 12
DEFIGARD/PHYSIOGARD Touch 7 User guide Electromagnetic interferences 12.7
Interference testing IEC 60601 test level Conformity lev- Electromagnetic environment - explanations
el
Conducted HF 3 Veff between 150 kHz and 3 V 3 ,5
IEC 61000-4-6 80 MHz outside of the ISM d = ------- P
3
frequency bandsa
d. For the frequency range between 150 kHz and 80 MHz, the field strength must be lower than 3 V/m.
Page 157
12 Technical Data
12.7 Electromagnetic interferences DEFIGARD/PHYSIOGARD Touch 7
Max. transmitting 3 ,5 12
d = ------- P d = ------ P 12 23
power of the 3 10 d = ------ P d = ------ P
10 10
transmitter (W) between 150 kHz and 80 between 150 kHz and
between 80 MHz and between 800 MHz and
MHz outside of the ISM 80 MHz within the ISM
800 MHz 2.5 GHz
frequency band frequency band
100 11.67 12 12 23
For transmitters with a max. transmitting power that is not listed in the above table, the recommended minimum distance d in metres (m) can
be calculated using a formula based on the transmitter's frequency, where P is the max. transmitting power of the transmitter in Watts (W)
(according to manufacturer data).
Note 1 These guidelines might not always be applicable. Electromagnetic radiation is influenced by absorption and reflection on structures,
objects and people.
Note 2 To calculate the recommended minimum distance of transmitters in the ISM frequency bands between 150 kHz and 80M
Hz and in the frequency band between 80 MHz and 2.5 GHz, the additional factor 10/3 is used to minimise the probability of interferences caused
by mobile/portable communication equipment that accidentally happens to be in the patient environment.
Page 158
Appendix 13
DEFIGARD/PHYSIOGARD Touch 7 User guide Accessories and disposables 13.1
13 Appendix
13.1 Accessories and disposables
Always use SCHILLER replacement parts and disposables, or products
approved by SCHILLER. Failure to do so may endanger essential performance,
life and/or invalidate the warranty.
Your local representative stocks all the disposables and accessories for the
DEFIGARD® Touch 7. A full list of all SCHILLER representatives can be found on the
SCHILLER website (www.schiller.ch).
Page 159
13 Appendix
13.2 Accessories DEFIGARD/PHYSIOGARD Touch 7 DEFIGARD/PHYSIOGARD Touch 7
Page 160
Appendix 13
DEFIGARD/PHYSIOGARD Touch 7 User guide Literature 13.3
13.3 Literature
European Resuscitation Council Guidelines 2015 for Cardiopulmonary Resuscitation and Emergency Cardiovascular
(2015) Care (
American Heart Association (2015) Guidelines 2015 for Cardiopulmonary Resuscitation and Emergency Cardiovascular
Care
Clinical experience with a low-ener- Jean-Philippe Didon, Guy Fontaine, Roger D. White, Irena Jekova, Johann-Jakob
gy pulsed biphasic waveform in out- Schmid, Albert Cansell; Clinical experience with a low-energy pulsed biphasic
of-hospital cardiac arrest waveform in out-of-hospital cardiac arrest, Resuscitation (2008) 76, pp 350—353.
13.4 Glossary
AED Automated external defibrillator
VT Ventricular tachycardia
VF Ventricular fibrillation
Art. no.: 0-48-0227 Rev.: g
Page 161
13 Appendix
13.4 Glossary DEFIGARD/PHYSIOGARD Touch 7
Page 162
Index 14
DEFIGARD/PHYSIOGARD Touch 7 User guide
14 Index
A I V
Accessories and disposables .............. 125 IBP Voice support ......................................... 93
Activating the audio alarm ..................... 39 IBP calibration .................................. 61
Alarm indicators ..................................... 39 IBP settings ...................................... 60
Alarm messages .................................... 38 Preparing IBP measurement ............ 59 W
Auto ..................................................... 115 Zeroing ............................................. 60 Warranty ................................................ 15
Internal defibrillation .............................. 89
B
Battery L
Battery life ...................................... 131 LEDs ..................................................... 24
Battery disposal ................................... 118
Battery type ......................................... 131
Biocompatibility ..................................... 20 M
Maintenance
Lifed Item Replacement ................. 123
C Maintenance interval ........................... 112
Charge control and monitoring ............ 135 Maintenance interval for the battery .... 118
Charging time ...................................... 135 Manual defibrillation .............................. 83
Charging Unit CS-1 Manual defibrillation using pads ............ 85
Input and Output Supplies .............. 130
Cleaning .................................. 119, 121
Cycle time shock – shock .................... 135 N
NIBP Menu ............................................ 58
NIBP softkey ......................................... 57
D
Danger of electric shock! ....................... 12
Danger of explosion .............................. 26 O
Default energy settings ........................ 135 Operating elements ............................... 22
Defibrillation - procedure ....................... 94 Operational readiness ........................... 32
Defibrillation pulse ............................... 134
Demand mode ....................................... 99
P
Pacemaker
E Fixed-rate mode (Fix) ....................... 99
ECG error messages ............................. 47 Pacemaker patients .............................. 46
ECG Menu ............................................. 50 Patient resistance ................................ 135
ECG, quick diagnosis ............................ 43 Physiological alarms ............................. 39
Error Detection .................................... 125
etCO2
etCO2 settings .................................. 67
S
Safety discharge ................................. 136
LED on the sensor ............................ 67
O2 concentration .............................. 67 Semiautomatic defibrillation .................. 92
Shock delivery ..................................... 136
Preparation ....................................... 67
SpO2 error messages ........................... 53
Sensor LED ...................................... 71
Zeroing ............................................. 66 SpO2 Menu ........................................... 52
SPO2 monitoring ................................... 50
Event marks .......................................... 85
Step 2 Analysis ..................................... 94
Art. no.: 0-48-0227 Rev.: g
Page 163
14 Index
DEFIGARD/PHYSIOGARD Touch 7
Page 164